cisplatin - Ontology Report - Rat Genome Database

Help | FTP Download | Citing RGD | Contact Us

Keyword

ONTOLOGY REPORT - ANNOTATIONS

Term:	cisplatin	go back to main search page
Accession:	CHEBI:27899	browse the term
Definition:	A platinum-containing anticancer drug that interacts with, and forms cross-links between, DNA and proteins. It is used as a neoplasm inhibitor to treat solid tumours, primarily of the testis and ovary.
Synonyms:	exact_synonym:	(SP-4-2)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloroplatinum; cis-diamminedichloridoplatinum(II); cis-diamminedichloroplatinum(II)
	related_synonym:	Briplatin; Cismaplat; Cl2H6N2Pt; H6Cl2N2Pt; InChI=1S/2ClH.2H3N.Pt/h21H;21H3;/q;;;;+2/p-2; InChIKey=LXZZYRPGZAFOLE-UHFFFAOYSA-L; Lederplatin; Neoplatin; Peyrone's chloride; Peyrone's salt; Platamine; Platinex; Platinol; Randa; [H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H]; cis-DDP; cis-[PtCl2(NH3)2]; cis-diamminedichloroplatinum; cis-diammineplatinum(II) dichloride; cis-dichlorodiammineplatinum(II); cis-platin; cisplatine; cisplatino; cisplatinum
	alt_id:	CHEBI:23314; CHEBI:3722
	xref_casrn:	15663-27-1
	xref:	ChEMBL:428069 "ChEMBL COMPOUND"; ChemIDplus:15663-27-1 "CAS Registry Number"; DrugBank:DB00515 "DrugBank"; Gmelin:2519 "Gmelin Registry Number"; KEGG COMPOUND:15663-27-1 "CAS Registry Number"; KEGG COMPOUND:C06911 "KEGG COMPOUND"; KEGG DRUG:D00275 "KEGG DRUG"
	xref_mesh:	MESH:D002945
	xref:	MolBase:25 "MolBase"; Patent:DE2318020 "Patent"; Patent:DE2329485 "Patent"

Rat
Mouse
Human
All
show annotations for term's descendants
Sort by:

cisplatin
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	A2M	alpha-2-macroglobulin		affects binding	EXP	12	9,220,304	9,268,558	RGD:6480464	CTD
G	A2M	alpha-2-macroglobulin		increases expression	ISO	12	9,220,304	9,268,558	RGD:6480464	CTD
G	AAK1	AP2 associated kinase 1		increases expression	ISO	2	69,685,127	69,870,977	RGD:6480464	CTD
G	AARS	alanyl-tRNA synthetase		multiple interactions	EXP	16	70,286,297	70,323,412	RGD:6480464	CTD
G	AASS	aminoadipate-semialdehyde synthase		decreases expression	ISO	7	121,713,598	121,784,344	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		affects response to substance	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		affects response to substance	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		decreases response to substance	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		increases expression	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		increases expression	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		decreases response to substance	ISO	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	ISO	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ACHE	acetylcholinesterase		decreases activity	ISO	7	100,487,615	100,493,541	RGD:6480464	CTD
G	ACHE	acetylcholinesterase		multiple interactions	ISO	7	100,487,615	100,493,541	RGD:6480464	CTD
G	ACIN1	apoptotic chromatin condensation inducer 1		increases phosphorylation	ISO	14	23,527,773	23,564,823	RGD:6480464	CTD
G	ACIN1	apoptotic chromatin condensation inducer 1		decreases phosphorylation	ISO	14	23,527,773	23,564,823	RGD:6480464	CTD
G	ACO2	aconitase 2, mitochondrial		increases expression	ISO	22	41,865,129	41,924,993	RGD:6480464	CTD
G	ACOX2	acyl-CoA oxidase 2, branched chain		increases expression	ISO	3	58,490,863	58,522,929	RGD:6480464	CTD
G	ACSL3	acyl-CoA synthetase long-chain family member 3		decreases response to substance	EXP	2	223,725,732	223,808,119	RGD:6480464	CTD
G	ACSL5	acyl-CoA synthetase long-chain family member 5		decreases expression	ISO	10	114,133,916	114,188,138	RGD:6480464	CTD
G	ACVR1	activin A receptor, type I		decreases expression	ISO	2	158,592,958	158,732,374	RGD:6480464	CTD
G	ACVR1C	activin A receptor, type IC		increases response to substance	EXP	2	158,383,279	158,485,399	RGD:6480464	CTD
G	ACVR1C	activin A receptor, type IC		multiple interactions	EXP	2	158,383,279	158,485,399	RGD:6480464	CTD
G	ACVR1C	activin A receptor, type IC		increases expression	EXP	2	158,383,279	158,485,399	RGD:6480464	CTD
G	ADAM10	ADAM metallopeptidase domain 10		affects response to substance	EXP	15	58,888,510	59,042,177	RGD:6480464	CTD
G	ADAM8	ADAM metallopeptidase domain 8		increases expression	ISO	10	135,075,920	135,090,407	RGD:6480464	CTD
G	ADAM9	ADAM metallopeptidase domain 9		decreases expression	ISO	8	38,854,505	38,962,780	RGD:6480464	CTD
G	ADAMTS15	ADAM metallopeptidase with thrombospondin type 1 motif, 15		decreases expression	ISO	11	130,318,869	130,346,539	RGD:6480464	CTD
G	ADCK3	aarF domain containing kinase 3		multiple interactions	EXP	1	227,127,938	227,175,246	RGD:6480464	CTD
G	ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide		increases expression	ISO	4	100,257,649	100,273,917	RGD:6480464	CTD
G	ADM	adrenomedullin		decreases expression	ISO	11	10,326,642	10,328,923	RGD:6480464	CTD
G	ADM	adrenomedullin		decreases expression	ISO	11	10,326,642	10,328,923	RGD:6480464	CTD
G	ADNP2	ADNP homeobox 2		increases phosphorylation	ISO	18	77,866,915	77,898,229	RGD:6480464	CTD
G	ADORA2B	adenosine A2b receptor		affects response to substance	EXP	17	15,848,231	15,879,210	RGD:6480464	CTD
G	ADRA1B	adrenoceptor alpha 1B		decreases expression	ISO	5	159,343,740	159,400,017	RGD:6480464	CTD
G	ADRM1	adhesion regulating molecule 1		multiple interactions	EXP	20	60,878,027	60,883,918	RGD:6480464	CTD
G	ADRM1	adhesion regulating molecule 1		multiple interactions	EXP	20	60,878,027	60,883,918	RGD:6480464	CTD
G	ADRM1	adhesion regulating molecule 1		increases expression	EXP	20	60,878,027	60,883,918	RGD:6480464	CTD
G	AEBP2	AE binding protein 2		decreases phosphorylation	ISO	12	19,592,608	19,675,173	RGD:6480464	CTD
G	AFF1	AF4/FMR2 family, member 1		decreases phosphorylation	ISO	4	87,856,154	88,062,206	RGD:6480464	CTD
G	AGAP1	ArfGAP with GTPase domain, ankyrin repeat and PH domain 1		decreases expression	ISO	2	236,402,733	237,040,444	RGD:6480464	CTD
G	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4		decreases expression	ISO	6	161,551,057	161,695,107	RGD:6480464	CTD
G	AHCY	adenosylhomocysteinase		increases expression	EXP	20	32,868,071	32,899,608	RGD:6480464	CTD
G	AHCYL1	adenosylhomocysteinase-like 1		affects response to substance	EXP	1	110,527,387	110,566,364	RGD:6480464	CTD
G	AHNAK	AHNAK nucleoprotein		decreases expression	ISO	11	62,201,016	62,314,332	RGD:6480464	CTD
G	AIF1	allograft inflammatory factor 1		decreases expression	ISO	6	31,582,994	31,584,798	RGD:6480464	CTD
G	AIF1L	allograft inflammatory factor 1-like		decreases expression	ISO	9	133,971,863	133,998,539	RGD:6480464	CTD
G	AIFM1	apoptosis-inducing factor, mitochondrion-associated, 1		multiple interactions	ISO	X	129,263,337	129,299,861	RGD:6480464	CTD
G	AIFM1	apoptosis-inducing factor, mitochondrion-associated, 1		affects localization	ISO	X	129,263,337	129,299,861	RGD:6480464	CTD
G	AIFM1	apoptosis-inducing factor, mitochondrion-associated, 1		increases expression	ISO	X	129,263,337	129,299,861	RGD:6480464	CTD
G	AKAP12	A kinase (PRKA) anchor protein 12		multiple interactions	EXP	6	151,561,134	151,679,694	RGD:6480464	CTD
G	AKAP12	A kinase (PRKA) anchor protein 12		increases expression	ISO	6	151,561,134	151,679,694	RGD:6480464	CTD
G	AKAP12	A kinase (PRKA) anchor protein 12		affects response to substance	EXP	6	151,561,134	151,679,694	RGD:6480464	CTD
G	AKAP8	A kinase (PRKA) anchor protein 8		increases phosphorylation	ISO	19	15,464,332	15,490,612	RGD:6480464	CTD
G	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)		decreases expression	EXP	7	134,127,107	134,143,888	RGD:6480464	CTD
G	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)		increases expression	ISO	7	134,127,107	134,143,888	RGD:6480464	CTD
G	AKR1B1	aldo-keto reductase family 1, member B1 (aldose reductase)		increases phosphorylation	ISO	7	134,127,107	134,143,888	RGD:6480464	CTD
G	AKR1C1	aldo-keto reductase family 1, member C1		decreases response to substance	EXP	10	5,005,454	5,020,158	RGD:6480464	CTD
G	AKR1C2	aldo-keto reductase family 1, member C2		decreases response to substance	EXP	10	5,029,967	5,060,225	RGD:6480464	CTD
G	AKR7A3	aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)		increases expression	ISO	1	19,609,057	19,615,280	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	EXP	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	EXP	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		decreases response to substance	EXP	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		decreases response to substance	EXP	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	EXP	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		decreases expression	EXP	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		decreases phosphorylation	EXP	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	EXP	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		decreases phosphorylation	ISO	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		decreases expression	ISO	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT2	v-akt murine thymoma viral oncogene homolog 2		increases expression	EXP	19	40,736,224	40,791,302	RGD:6480464	CTD
G	ALAS2	aminolevulinate, delta-, synthase 2		decreases expression	ISO	X	55,035,488	55,057,497	RGD:6480464	CTD
G	ALB	albumin		affects binding	EXP	4	74,269,972	74,287,129	RGD:6480464	CTD
G	ALB	albumin		multiple interactions	EXP	4	74,269,972	74,287,129	RGD:6480464	CTD
G	ALDH1A1	aldehyde dehydrogenase 1 family, member A1		increases expression	ISO	9	75,515,578	75,568,233	RGD:6480464	CTD
G	ALDH1A1	aldehyde dehydrogenase 1 family, member A1		increases expression	ISO	9	75,515,578	75,568,233	RGD:6480464	CTD
G	ALDOA	aldolase A, fructose-bisphosphate		affects expression	ISO	16	30,064,411	30,081,741	RGD:6480464	CTD
G	ALKBH2	alkB, alkylation repair homolog 2 (E. coli)		decreases response to substance	EXP	12	109,525,993	109,531,293	RGD:6480464	CTD
G	ALOX12	arachidonate 12-lipoxygenase		increases expression	ISO	17	6,899,384	6,914,055	RGD:6480464	CTD
G	ALOX12P2	arachidonate 12-lipoxygenase pseudogene 2		increases expression	ISO	17	6,756,895	6,803,668	RGD:6480464	CTD
G	ALOX5AP	arachidonate 5-lipoxygenase-activating protein		increases expression	ISO	13	31,287,615	31,338,565	RGD:6480464	CTD
G	AMY1A	amylase, alpha 1A (salivary)		multiple interactions	ISO	1	104,198,141	104,207,173	RGD:6480464	CTD
G	ANK2	ankyrin 2, neuronal		decreases expression	ISO	4	113,739,239	114,304,896	RGD:6480464	CTD
G	ANKRD1	ankyrin repeat domain 1 (cardiac muscle)		increases expression	ISO	10	92,671,857	92,681,032	RGD:6480464	CTD
G	ANKRD1	ankyrin repeat domain 1 (cardiac muscle)		decreases expression	ISO	10	92,671,857	92,681,032	RGD:6480464	CTD
G	ANLN	anillin, actin binding protein		increases expression	ISO	7	36,429,432	36,493,400	RGD:6480464	CTD
G	ANLN	anillin, actin binding protein		decreases expression	ISO	7	36,429,432	36,493,400	RGD:6480464	CTD
G	ANO2	anoctamin 2		decreases expression	ISO	12	5,671,817	6,055,398	RGD:6480464	CTD
G	ANP32A	acidic (leucine-rich) nuclear phosphoprotein 32 family, member A		decreases expression	ISO	15	69,070,874	69,113,261	RGD:6480464	CTD
G	ANP32A	acidic (leucine-rich) nuclear phosphoprotein 32 family, member A		multiple interactions	EXP	15	69,070,874	69,113,261	RGD:6480464	CTD
G	ANXA1	annexin A1		increases expression	EXP	9	75,766,781	75,785,307	RGD:6480464	CTD
G	ANXA1	annexin A1		affects response to substance	EXP	9	75,766,781	75,785,307	RGD:6480464	CTD
G	ANXA1	annexin A1		increases expression	ISO	9	75,766,781	75,785,307	RGD:6480464	CTD
G	ANXA10	annexin A10		multiple interactions	EXP	4	169,013,688	169,108,893	RGD:6480464	CTD
G	ANXA5	annexin A5		decreases expression	EXP	4	122,589,152	122,618,147	RGD:6480464	CTD
G	ANXA5	annexin A5		increases expression	ISO	4	122,589,152	122,618,147	RGD:6480464	CTD
G	ANXA7	annexin A7		increases expression	ISO	10	75,135,189	75,173,841	RGD:6480464	CTD
G	APAF1	apoptotic peptidase activating factor 1		multiple interactions	EXP	12	99,039,078	99,129,211	RGD:6480464	CTD
G	APAF1	apoptotic peptidase activating factor 1		increases expression	ISO	12	99,039,078	99,129,211	RGD:6480464	CTD
G	APEX1	APEX nuclease (multifunctional DNA repair enzyme) 1		decreases response to substance	EXP	14	20,923,290	20,925,931	RGD:6480464	CTD
G	APEX1	APEX nuclease (multifunctional DNA repair enzyme) 1		multiple interactions	EXP	14	20,923,290	20,925,931	RGD:6480464	CTD
G	APEX1	APEX nuclease (multifunctional DNA repair enzyme) 1		increases acetylation	EXP	14	20,923,290	20,925,931	RGD:6480464	CTD
G	APEX1	APEX nuclease (multifunctional DNA repair enzyme) 1		decreases expression	ISO	14	20,923,290	20,925,931	RGD:6480464	CTD
G	APEX1	APEX nuclease (multifunctional DNA repair enzyme) 1		multiple interactions	ISO	14	20,923,290	20,925,931	RGD:6480464	CTD
G	APLP2	amyloid beta (A4) precursor-like protein 2		multiple interactions	EXP	11	129,939,716	130,014,706	RGD:6480464	CTD
G	APOE	apolipoprotein E		increases expression	ISO	19	45,409,039	45,412,650	RGD:6480464	CTD
G	ATF2	activating transcription factor 2		decreases response to substance	EXP	2	175,936,978	176,032,934	RGD:6480464	CTD
G	ATF2	activating transcription factor 2		increases phosphorylation	ISO	2	175,936,978	176,032,934	RGD:6480464	CTD
G	ATF3	activating transcription factor 3		multiple interactions	EXP	1	212,738,676	212,794,119	RGD:6480464	CTD
G	ATF3	activating transcription factor 3		increases expression	EXP	1	212,738,676	212,794,119	RGD:6480464	CTD
G	ATF4	activating transcription factor 4 (tax-responsive enhancer element B67)		increases expression	ISO	22	39,916,569	39,918,691	RGD:6480464	CTD
G	ATF4	activating transcription factor 4 (tax-responsive enhancer element B67)		multiple interactions	ISO	22	39,916,569	39,918,691	RGD:6480464	CTD
G	ATF5	activating transcription factor 5		decreases expression	ISO	19	50,431,959	50,437,193	RGD:6480464	CTD
G	ATG12	autophagy related 12		decreases expression	ISO	5	115,163,893	115,177,548	RGD:6480464	CTD
G	ATG5	autophagy related 5		multiple interactions	EXP	6	106,632,352	106,773,695	RGD:6480464	CTD
G	ATG5	autophagy related 5		decreases response to substance	EXP	6	106,632,352	106,773,695	RGD:6480464	CTD
G	ATM	ataxia telangiectasia mutated		increases expression	EXP	11	108,093,559	108,239,826	RGD:6480464	CTD
G	ATM	ataxia telangiectasia mutated		multiple interactions	EXP	11	108,093,559	108,239,826	RGD:6480464	CTD
G	ATM	ataxia telangiectasia mutated		increases expression	ISO	11	108,093,559	108,239,826	RGD:6480464	CTD
G	ATM	ataxia telangiectasia mutated		increases response to substance	EXP	11	108,093,559	108,239,826	RGD:6480464	CTD
G	ATM	ataxia telangiectasia mutated		increases phosphorylation	ISO	11	108,093,559	108,239,826	RGD:6480464	CTD
G	ATN1	atrophin 1		increases expression	ISO	12	7,033,626	7,051,484	RGD:6480464	CTD
G	ATP10A	ATPase, class V, type 10A		decreases expression	ISO	15	25,923,859	26,108,349	RGD:6480464	CTD
G	ATP10D	ATPase, class V, type 10D		decreases expression	ISO	4	47,487,410	47,595,503	RGD:6480464	CTD
G	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide		decreases expression	ISO	1	116,915,795	116,947,396	RGD:6480464	CTD
G	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide		multiple interactions	EXP	1	169,075,947	169,101,960	RGD:6480464	CTD
G	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide		decreases expression	ISO	3	141,595,470	141,645,382	RGD:6480464	CTD
G	ATP2A2	ATPase, Ca++ transporting, cardiac muscle, slow twitch 2		decreases expression	ISO	12	110,719,032	110,788,898	RGD:6480464	CTD
G	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle		increases expression	ISO	18	43,664,110	43,684,199	RGD:6480464	CTD
G	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)		multiple interactions	EXP	17	46,970,148	46,973,233	RGD:6480464	CTD
G	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E		increases expression	ISO	4	666,225	668,127	RGD:6480464	CTD
G	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G		increases expression	ISO	11	118,272,104	118,280,562	RGD:6480464	CTD
G	ATP5O	ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit		increases expression	ISO	21	35,275,757	35,288,158	RGD:6480464	CTD
G	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2		affects response to substance	EXP	6	31,512,228	31,514,625	RGD:6480464	CTD
G	ATP7A	ATPase, Cu++ transporting, alpha polypeptide		decreases response to substance	ISO	X	77,166,194	77,305,892	RGD:6480464	CTD
G	ATP7A	ATPase, Cu++ transporting, alpha polypeptide		increases expression	ISO	X	77,166,194	77,305,892	RGD:6480464	CTD
G	ATP7B	ATPase, Cu++ transporting, beta polypeptide		decreases response to substance	EXP	13	52,506,805	52,585,630	RGD:6480464	CTD
G	ATP7B	ATPase, Cu++ transporting, beta polypeptide		multiple interactions	EXP	13	52,506,805	52,585,630	RGD:6480464	CTD
G	ATP7B	ATPase, Cu++ transporting, beta polypeptide		increases secretion	EXP	13	52,506,805	52,585,630	RGD:6480464	CTD
G	ATP7B	ATPase, Cu++ transporting, beta polypeptide		decreases response to substance	ISO	13	52,506,805	52,585,630	RGD:6480464	CTD
G	ATR	ataxia telangiectasia and Rad3 related		increases phosphorylation	ISO	3	142,168,077	142,297,668	RGD:6480464	CTD
G	ATR	ataxia telangiectasia and Rad3 related		multiple interactions	ISO	3	142,168,077	142,297,668	RGD:6480464	CTD
G	ATR	ataxia telangiectasia and Rad3 related		multiple interactions	EXP	3	142,168,077	142,297,668	RGD:6480464	CTD
G	ATR	ataxia telangiectasia and Rad3 related		multiple interactions	EXP	3	142,168,077	142,297,668	RGD:6480464	CTD
G	ATR	ataxia telangiectasia and Rad3 related		multiple interactions	EXP	3	142,168,077	142,297,668	RGD:6480464	CTD
G	ATR	ataxia telangiectasia and Rad3 related		increases activity	EXP	3	142,168,077	142,297,668	RGD:6480464	CTD
G	ATR	ataxia telangiectasia and Rad3 related		multiple interactions	EXP	3	142,168,077	142,297,668	RGD:6480464	CTD
G	ATR	ataxia telangiectasia and Rad3 related		decreases response to substance	EXP	3	142,168,077	142,297,668	RGD:6480464	CTD
G	ATR	ataxia telangiectasia and Rad3 related		increases phosphorylation	ISO	3	142,168,077	142,297,668	RGD:6480464	CTD
G	ATRNL1	attractin-like 1		decreases expression	ISO	10	116,853,124	117,708,496	RGD:6480464	CTD
G	AURKA	aurora kinase A		multiple interactions	EXP	20	54,944,445	54,967,351	RGD:6480464	CTD
G	AURKA	aurora kinase A		increases expression	ISO	20	54,944,445	54,967,351	RGD:6480464	CTD
G	AURKA	aurora kinase A		decreases response to substance	EXP	20	54,944,445	54,967,351	RGD:6480464	CTD
G	AVPI1	arginine vasopressin-induced 1		multiple interactions	EXP	10	99,437,181	99,447,015	RGD:6480464	CTD
G	AXL	AXL receptor tyrosine kinase		increases expression	EXP	19	41,725,108	41,767,671	RGD:6480464	CTD
G	AXL	AXL receptor tyrosine kinase		increases expression	ISO	19	41,725,108	41,767,671	RGD:6480464	CTD
G	AXL	AXL receptor tyrosine kinase		decreases expression	ISO	19	41,725,108	41,767,671	RGD:6480464	CTD
G	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4		affects response to substance	EXP	6	33,244,917	33,246,602	RGD:6480464	CTD
G	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)		increases expression	ISO	9	104,122,699	104,147,287	RGD:6480464	CTD
G	BACH1	BTB and CNC homology 1, basic leucine zipper transcription factor 1		affects response to substance	EXP	21	30,671,220	30,734,217	RGD:6480464	CTD
G	BAD	BCL2-associated agonist of cell death		decreases response to substance	EXP	11	64,037,300	64,052,176	RGD:6480464	CTD
G	BAD	BCL2-associated agonist of cell death		increases expression	EXP	11	64,037,300	64,052,176	RGD:6480464	CTD
G	BAD	BCL2-associated agonist of cell death		multiple interactions	EXP	11	64,037,300	64,052,176	RGD:6480464	CTD
G	BAD	BCL2-associated agonist of cell death		multiple interactions	EXP	11	64,037,300	64,052,176	RGD:6480464	CTD
G	BAD	BCL2-associated agonist of cell death		multiple interactions	EXP	11	64,037,300	64,052,176	RGD:6480464	CTD
G	BAG5	BCL2-associated athanogene 5		multiple interactions	EXP	14	104,022,881	104,029,151	RGD:6480464	CTD
G	BAG6	BCL2-associated athanogene 6		multiple interactions	EXP	6	31,606,805	31,620,477	RGD:6480464	CTD
G	BAK1	BCL2-antagonist/killer 1		multiple interactions	ISO	6	33,540,323	33,548,070	RGD:6480464	CTD
G	BAK1	BCL2-antagonist/killer 1		multiple interactions	EXP	6	33,540,323	33,548,070	RGD:6480464	CTD
G	BANF1	barrier to autointegration factor 1		decreases expression	ISO	11	65,769,550	65,771,617	RGD:6480464	CTD
G	BARD1	BRCA1 associated RING domain 1		increases phosphorylation	ISO	2	215,593,262	215,674,428	RGD:6480464	CTD
G	BASP1	brain abundant, membrane attached signal protein 1		decreases expression	ISO	5	17,217,750	17,276,943	RGD:6480464	CTD
G	BATF3	basic leucine zipper transcription factor, ATF-like 3		multiple interactions	EXP	1	212,859,759	212,873,327	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		decreases response to substance	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		affects localization	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		increases expression	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		increases expression	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		increases localization	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	ISO	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	ISO	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	ISO	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		affects localization	ISO	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		increases activity	ISO	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	ISO	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	ISO	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		increases expression	ISO	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	ISO	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	ISO	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases response to substance	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases response to substance	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases expression	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases expression	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		increases expression	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	ISO	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		affects response to substance	ISO	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases expression	ISO	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases expression	ISO	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases response to substance	ISO	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	ISO	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	ISO	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases expression	ISO	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases expression	ISO	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2L1	BCL2-like 1		multiple interactions	EXP	20	30,252,261	30,310,656	RGD:6480464	CTD
G	BCL2L1	BCL2-like 1		decreases response to substance	EXP	20	30,252,261	30,310,656	RGD:6480464	CTD
G	BCL2L1	BCL2-like 1		decreases response to substance	EXP	20	30,252,261	30,310,656	RGD:6480464	CTD
G	BCL2L1	BCL2-like 1		decreases expression	EXP	20	30,252,261	30,310,656	RGD:6480464	CTD
G	BCL2L1	BCL2-like 1		multiple interactions	EXP	20	30,252,261	30,310,656	RGD:6480464	CTD
G	BCL2L1	BCL2-like 1		decreases expression	EXP	20	30,252,261	30,310,656	RGD:6480464	CTD
G	BCL2L1	BCL2-like 1		increases degradation	EXP	20	30,252,261	30,310,656	RGD:6480464	CTD
G	BCL2L1	BCL2-like 1		increases expression	EXP	20	30,252,261	30,310,656	RGD:6480464	CTD
G	BCL2L1	BCL2-like 1		multiple interactions	EXP	20	30,252,261	30,310,656	RGD:6480464	CTD
G	BCL2L1	BCL2-like 1		multiple interactions	EXP	20	30,252,261	30,310,656	RGD:6480464	CTD
G	BCL2L1	BCL2-like 1		multiple interactions	EXP	20	30,252,261	30,310,656	RGD:6480464	CTD
G	BCL2L1	BCL2-like 1		multiple interactions	EXP	20	30,252,261	30,310,656	RGD:6480464	CTD
G	BCL2L1	BCL2-like 1		multiple interactions	EXP	20	30,252,261	30,310,656	RGD:6480464	CTD
G	BCL2L1	BCL2-like 1		multiple interactions	EXP	20	30,252,261	30,310,656	RGD:6480464	CTD
G	BCL2L1	BCL2-like 1		multiple interactions	EXP	20	30,252,261	30,310,656	RGD:6480464	CTD
G	BCL2L1	BCL2-like 1		multiple interactions	ISO	20	30,252,261	30,310,656	RGD:6480464	CTD
G	BCL2L1	BCL2-like 1		decreases expression	ISO	20	30,252,261	30,310,656	RGD:6480464	CTD
G	BCL2L1	BCL2-like 1		decreases expression	ISO	20	30,252,261	30,310,656	RGD:6480464	CTD
G	BCL2L11	BCL2-like 11 (apoptosis facilitator)		multiple interactions	EXP	2	111,878,491	111,926,022	RGD:6480464	CTD
G	BCL2L11	BCL2-like 11 (apoptosis facilitator)		increases expression	EXP	2	111,878,491	111,926,022	RGD:6480464	CTD
G	BCL2L12	BCL2-like 12 (proline rich)		decreases expression	EXP	19	50,168,399	50,177,173	RGD:6480464	CTD
G	BCL2L2	BCL2-like 2		multiple interactions	EXP	14	23,775,971	23,780,968	RGD:6480464	CTD
G	BCL6	B-cell CLL/lymphoma 6		increases expression	EXP	3	187,439,165	187,463,513	RGD:6480464	CTD
G	BCLAF1	BCL2-associated transcription factor 1		multiple interactions	EXP	6	136,578,001	136,610,989	RGD:6480464	CTD
G	BDH1	3-hydroxybutyrate dehydrogenase, type 1		decreases expression	ISO	3	197,236,654	197,300,194	RGD:6480464	CTD
G	BDH2	3-hydroxybutyrate dehydrogenase, type 2		decreases expression	ISO	4	103,998,782	104,021,024	RGD:6480464	CTD
G	BDNF	brain-derived neurotrophic factor		decreases expression	ISO	11	27,676,440	27,743,605	RGD:6480464	CTD
G	BECN1	beclin 1, autophagy related		multiple interactions	EXP	17	40,962,150	40,976,310	RGD:6480464	CTD
G	BECN1	beclin 1, autophagy related		increases expression	ISO	17	40,962,150	40,976,310	RGD:6480464	CTD
G	BEND5	BEN domain containing 5		decreases expression	ISO	1	49,193,539	49,242,547	RGD:6480464	CTD
G	BEX1	brain expressed, X-linked 1		decreases expression	ISO	X	102,317,581	102,319,168	RGD:6480464	CTD
G	BGN	biglycan		decreases expression	ISO	X	152,760,347	152,775,004	RGD:6480464	CTD
G	BHLHE40	basic helix-loop-helix family, member e40		decreases expression	ISO	3	5,021,097	5,026,866	RGD:6480464	CTD
G	BHLHE41	basic helix-loop-helix family, member e41		multiple interactions	EXP	12	26,272,959	26,278,003	RGD:6480464	CTD
G	BHLHE41	basic helix-loop-helix family, member e41		decreases expression	ISO	12	26,272,959	26,278,003	RGD:6480464	CTD
G	BHMT	betaine--homocysteine S-methyltransferase		increases expression	ISO	5	78,407,604	78,428,113	RGD:6480464	CTD
G	BID	BH3 interacting domain death agonist		multiple interactions	EXP	22	18,216,906	18,257,431	RGD:6480464	CTD
G	BID	BH3 interacting domain death agonist		multiple interactions	EXP	22	18,216,906	18,257,431	RGD:6480464	CTD
G	BID	BH3 interacting domain death agonist		multiple interactions	EXP	22	18,216,906	18,257,431	RGD:6480464	CTD
G	BID	BH3 interacting domain death agonist		increases activity	EXP	22	18,216,906	18,257,431	RGD:6480464	CTD
G	BID	BH3 interacting domain death agonist		increases expression	ISO	22	18,216,906	18,257,431	RGD:6480464	CTD
G	BID	BH3 interacting domain death agonist		multiple interactions	EXP	22	18,216,906	18,257,431	RGD:6480464	CTD
G	BID	BH3 interacting domain death agonist		multiple interactions	EXP	22	18,216,906	18,257,431	RGD:6480464	CTD
G	BIK	BCL2-interacting killer (apoptosis-inducing)		increases expression	EXP	22	43,506,754	43,525,718	RGD:6480464	CTD
G	BIK	BCL2-interacting killer (apoptosis-inducing)		multiple interactions	EXP	22	43,506,754	43,525,718	RGD:6480464	CTD
G	BIN1	bridging integrator 1		multiple interactions	EXP	2	127,805,599	127,864,903	RGD:6480464	CTD
G	BIN1	bridging integrator 1		increases response to substance	EXP	2	127,805,599	127,864,903	RGD:6480464	CTD
G	BIN2	bridging integrator 2		decreases phosphorylation	ISO	12	51,674,822	51,717,938	RGD:6480464	CTD
G	BIRC2	baculoviral IAP repeat containing 2		decreases response to substance	EXP	11	102,217,913	102,249,401	RGD:6480464	CTD
G	BIRC3	baculoviral IAP repeat containing 3		decreases expression	EXP	11	102,188,181	102,210,134	RGD:6480464	CTD
G	BIRC3	baculoviral IAP repeat containing 3		decreases response to substance	EXP	11	102,188,181	102,210,134	RGD:6480464	CTD
G	BIRC5	baculoviral IAP repeat containing 5		decreases response to substance	EXP	17	76,210,277	76,221,716	RGD:6480464	CTD
G	BIRC5	baculoviral IAP repeat containing 5		multiple interactions	EXP	17	76,210,277	76,221,716	RGD:6480464	CTD
G	BIRC5	baculoviral IAP repeat containing 5		multiple interactions	EXP	17	76,210,277	76,221,716	RGD:6480464	CTD
G	BIRC5	baculoviral IAP repeat containing 5		multiple interactions	EXP	17	76,210,277	76,221,716	RGD:6480464	CTD
G	BIRC5	baculoviral IAP repeat containing 5		decreases expression	EXP	17	76,210,277	76,221,716	RGD:6480464	CTD
G	BIRC5	baculoviral IAP repeat containing 5		decreases expression	EXP	17	76,210,277	76,221,716	RGD:6480464	CTD
G	BIRC5	baculoviral IAP repeat containing 5		multiple interactions	EXP	17	76,210,277	76,221,716	RGD:6480464	CTD
G	BIRC5	baculoviral IAP repeat containing 5		increases expression	EXP	17	76,210,277	76,221,716	RGD:6480464	CTD
G	BIRC5	baculoviral IAP repeat containing 5		increases expression	EXP	17	76,210,277	76,221,716	RGD:6480464	CTD
G	BIRC5	baculoviral IAP repeat containing 5		increases expression	ISO	17	76,210,277	76,221,716	RGD:6480464	CTD
G	BIRC5	baculoviral IAP repeat containing 5		multiple interactions	EXP	17	76,210,277	76,221,716	RGD:6480464	CTD
G	BIRC5	baculoviral IAP repeat containing 5		multiple interactions	EXP	17	76,210,277	76,221,716	RGD:6480464	CTD
G	BRIP1	BRCA1 interacting protein C-terminal helicase 1		decreases response to substance	EXP	17	59,756,547	59,940,920	RGD:6480464	CTD
G	BRMS1	breast cancer metastasis suppressor 1		multiple interactions	EXP	11	66,104,804	66,112,582	RGD:6480464	CTD
G	BSG	basigin (Ok blood group)		decreases response to substance	EXP	19	571,277	583,493	RGD:6480464	CTD
G	BTG1	B-cell translocation gene 1, anti-proliferative		decreases expression	ISO	12	92,534,054	92,539,673	RGD:6480464	CTD
G	BTG1	B-cell translocation gene 1, anti-proliferative		multiple interactions	EXP	12	92,534,054	92,539,673	RGD:6480464	CTD
G	BTG2	BTG family, member 2		affects response to substance	EXP	1	203,274,664	203,278,730	RGD:6480464	CTD
G	BTG2	BTG family, member 2		increases expression	EXP	1	203,274,664	203,278,730	RGD:6480464	CTD
G	BUB1	BUB1 mitotic checkpoint serine/threonine kinase		multiple interactions	EXP	2	111,395,409	111,435,684	RGD:6480464	CTD
G	BUB1	BUB1 mitotic checkpoint serine/threonine kinase		increases expression	ISO	2	111,395,409	111,435,684	RGD:6480464	CTD
G	BUB1B	BUB1 mitotic checkpoint serine/threonine kinase B		multiple interactions	EXP	15	40,453,210	40,513,337	RGD:6480464	CTD
G	BUB1B	BUB1 mitotic checkpoint serine/threonine kinase B		increases expression	ISO	15	40,453,210	40,513,337	RGD:6480464	CTD
G	C11orf68	chromosome 11 open reading frame 68		affects response to substance	EXP	11	65,684,281	65,686,531	RGD:6480464	CTD
G	C12orf5	chromosome 12 open reading frame 5		increases expression	EXP	12	4,430,359	4,469,194	RGD:6480464	CTD
G	C1D	C1D nuclear receptor corepressor		multiple interactions	EXP	2	68,269,332	68,290,159	RGD:6480464	CTD
G	C1orf63	chromosome 1 open reading frame 63		increases expression	EXP	1	25,568,740	25,573,985	RGD:6480464	CTD
G	C1QA	complement component 1, q subcomponent, A chain		decreases expression	ISO	1	22,963,118	22,966,175	RGD:6480464	CTD
G	C1QBP	complement component 1, q subcomponent binding protein		decreases expression	ISO	17	5,336,099	5,342,471	RGD:6480464	CTD
G	C3	complement component 3		multiple interactions	EXP	19	6,677,846	6,720,662	RGD:6480464	CTD
G	C4orf29	chromosome 4 open reading frame 29		affects response to substance	EXP	4	128,886,461	128,952,468	RGD:6480464	CTD
G	C7orf55	chromosome 7 open reading frame 55		increases expression	ISO	7	139,025,196	139,031,065	RGD:6480464	CTD
G	CA14	carbonic anhydrase XIV		decreases expression	ISO	1	150,230,218	150,237,478	RGD:6480464	CTD
G	CA2	carbonic anhydrase II		affects response to substance	EXP	8	86,376,131	86,393,721	RGD:6480464	CTD
G	CA3	carbonic anhydrase III, muscle specific		increases expression	ISO	8	86,351,056	86,361,269	RGD:6480464	CTD
G	CA3	carbonic anhydrase III, muscle specific		decreases expression	ISO	8	86,351,056	86,361,269	RGD:6480464	CTD
G	CACNA1A	calcium channel, voltage-dependent, P/Q type, alpha 1A subunit		increases expression	ISO	19	13,317,256	13,617,274	RGD:6480464	CTD
G	CACNA1C	calcium channel, voltage-dependent, L type, alpha 1C subunit		decreases expression	ISO	12	2,162,416	2,807,115	RGD:6480464	CTD
G	CACYBP	calcyclin binding protein		multiple interactions	EXP	1	174,968,571	174,981,163	RGD:6480464	CTD
G	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase		multiple interactions	EXP	2	27,440,258	27,466,654	RGD:6480464	CTD
G	CADPS2	Ca++-dependent secretion activator 2		decreases expression	ISO	7	121,958,478	122,526,813	RGD:6480464	CTD
G	CALB1	calbindin 1, 28kDa		decreases expression	ISO	8	91,070,838	91,095,107	RGD:6480464	CTD
G	CALCB	calcitonin-related polypeptide beta		affects response to substance	EXP	11	15,095,146	15,100,177	RGD:6480464	CTD
G	CALD1	caldesmon 1		decreases expression	ISO	7	134,464,164	134,655,480	RGD:6480464	CTD
G	CALR	calreticulin		decreases expression	ISO	19	13,049,414	13,055,304	RGD:6480464	CTD
G	CAMK2D	calcium/calmodulin-dependent protein kinase II delta		decreases expression	ISO	4	114,372,188	114,683,083	RGD:6480464	CTD
G	CAMKMT	calmodulin-lysine N-methyltransferase		decreases expression	ISO	2	44,589,043	44,999,731	RGD:6480464	CTD
G	CAND1	cullin-associated and neddylation-dissociated 1		increases expression	ISO	12	67,663,061	67,708,388	RGD:6480464	CTD
G	CANX	calnexin		multiple interactions	EXP	5	179,125,930	179,158,642	RGD:6480464	CTD
G	CANX	calnexin		decreases expression	ISO	5	179,125,930	179,158,642	RGD:6480464	CTD
G	CAPN1	calpain 1, (mu/I) large subunit		multiple interactions	EXP	11	64,948,686	64,979,477	RGD:6480464	CTD
G	CAPN1	calpain 1, (mu/I) large subunit		increases response to substance	EXP	11	64,948,686	64,979,477	RGD:6480464	CTD
G	CAPN2	calpain 2, (m/II) large subunit		decreases activity	ISO	1	223,889,295	223,963,720	RGD:6480464	CTD
G	CAPN2	calpain 2, (m/II) large subunit		decreases expression	ISO	1	223,889,295	223,963,720	RGD:6480464	CTD
G	CAPZA2	capping protein (actin filament) muscle Z-line, alpha 2		multiple interactions	EXP	7	116,502,563	116,559,313	RGD:6480464	CTD
G	CASP1	caspase 1, apoptosis-related cysteine peptidase		increases activity	ISO	11	104,896,235	104,905,884	RGD:6480464	CTD
G	CASP1	caspase 1, apoptosis-related cysteine peptidase		multiple interactions	ISO	11	104,896,235	104,905,884	RGD:6480464	CTD
G	CASP12	caspase 12 (gene/pseudogene)		multiple interactions	EXP	11	104,756,445	104,769,397	RGD:6480464	CTD
G	CASP12	caspase 12 (gene/pseudogene)		multiple interactions	ISO	11	104,756,445	104,769,397	RGD:6480464	CTD
G	CASP12	caspase 12 (gene/pseudogene)		increases cleavage	ISO	11	104,756,445	104,769,397	RGD:6480464	CTD
G	CASP12	caspase 12 (gene/pseudogene)		affects cleavage	ISO	11	104,756,445	104,769,397	RGD:6480464	CTD
G	CASP12	caspase 12 (gene/pseudogene)		multiple interactions	ISO	11	104,756,445	104,769,397	RGD:6480464	CTD
G	CASP2	caspase 2, apoptosis-related cysteine peptidase		increases cleavage	EXP	7	142,985,308	143,004,789	RGD:6480464	CTD
G	CASP2	caspase 2, apoptosis-related cysteine peptidase		increases activity	ISO	7	142,985,308	143,004,789	RGD:6480464	CTD
G	CASP2	caspase 2, apoptosis-related cysteine peptidase		multiple interactions	ISO	7	142,985,308	143,004,789	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		increases activity	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		increases cleavage	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		increases expression	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		increases expression	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP4	caspase 4, apoptosis-related cysteine peptidase		multiple interactions	EXP	11	104,813,594	104,839,325	RGD:6480464	CTD
G	CASP4	caspase 4, apoptosis-related cysteine peptidase		multiple interactions	EXP	11	104,813,594	104,839,325	RGD:6480464	CTD
G	CASP6	caspase 6, apoptosis-related cysteine peptidase		multiple interactions	ISO	4	110,609,785	110,624,629	RGD:6480464	CTD
G	CASP7	caspase 7, apoptosis-related cysteine peptidase		multiple interactions	EXP	10	115,438,921	115,490,668	RGD:6480464	CTD
G	CASP7	caspase 7, apoptosis-related cysteine peptidase		multiple interactions	EXP	10	115,438,921	115,490,668	RGD:6480464	CTD
G	CASP7	caspase 7, apoptosis-related cysteine peptidase		increases activity	EXP	10	115,438,921	115,490,668	RGD:6480464	CTD
G	CASP7	caspase 7, apoptosis-related cysteine peptidase		multiple interactions	EXP	10	115,438,921	115,490,668	RGD:6480464	CTD
G	CASP7	caspase 7, apoptosis-related cysteine peptidase		multiple interactions	ISO	10	115,438,921	115,490,668	RGD:6480464	CTD
G	CASP7	caspase 7, apoptosis-related cysteine peptidase		multiple interactions	ISO	10	115,438,921	115,490,668	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		multiple interactions	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		multiple interactions	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		multiple interactions	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		multiple interactions	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		decreases response to substance	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		multiple interactions	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		multiple interactions	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		multiple interactions	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		multiple interactions	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		multiple interactions	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		increases activity	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		increases cleavage	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		increases expression	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		multiple interactions	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		multiple interactions	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		increases expression	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		multiple interactions	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		multiple interactions	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		multiple interactions	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		multiple interactions	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		multiple interactions	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		increases activity	ISO	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		increases expression	ISO	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		decreases expression	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		increases activity	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		increases cleavage	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		increases expression	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	ISO	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		increases activity	ISO	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		increases cleavage	ISO	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	ISO	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		increases expression	ISO	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CAST	calpastatin		increases expression	ISO	5	95,997,741	96,110,387	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	EXP	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		decreases response to substance	EXP	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		decreases activity	EXP	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		decreases expression	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	EXP	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		decreases expression	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		decreases expression	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		increases expression	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		decreases activity	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAV1	caveolin 1, caveolae protein, 22kDa		affects response to substance	EXP	7	116,164,839	116,201,239	RGD:6480464	CTD
G	CAV1	caveolin 1, caveolae protein, 22kDa		affects expression	ISO	7	116,164,839	116,201,239	RGD:6480464	CTD
G	CAV1	caveolin 1, caveolae protein, 22kDa		decreases expression	ISO	7	116,164,839	116,201,239	RGD:6480464	CTD
G	CBX6	chromobox homolog 6		increases expression	ISO	22	39,260,243	39,268,258	RGD:6480464	CTD
G	CCAR1	cell division cycle and apoptosis regulator 1		increases expression	ISO	10	70,480,971	70,551,309	RGD:6480464	CTD
G	CCBL1	cysteine conjugate-beta lyase, cytoplasmic		affects response to substance	ISO	9	131,595,392	131,644,354	RGD:6480464	CTD
G	CCDC85B	coiled-coil domain containing 85B		affects response to substance	EXP	11	65,657,875	65,659,106	RGD:6480464	CTD
G	CCL1	chemokine (C-C motif) ligand 1		increases expression	ISO	17	32,687,399	32,690,252	RGD:6480464	CTD
G	CCL13	chemokine (C-C motif) ligand 13		increases expression	ISO	17	32,683,471	32,685,629	RGD:6480464	CTD
G	CCL2	chemokine (C-C motif) ligand 2		increases expression	ISO	17	32,582,296	32,584,222	RGD:6480464	CTD
G	CCL2	chemokine (C-C motif) ligand 2		multiple interactions	ISO	17	32,582,296	32,584,222	RGD:6480464	CTD
G	CCL2	chemokine (C-C motif) ligand 2		multiple interactions	ISO	17	32,582,296	32,584,222	RGD:6480464	CTD
G	CCL2	chemokine (C-C motif) ligand 2		decreases expression	ISO	17	32,582,296	32,584,222	RGD:6480464	CTD
G	CCL5	chemokine (C-C motif) ligand 5		multiple interactions	ISO	17	34,198,495	34,207,377	RGD:6480464	CTD
G	CCL5	chemokine (C-C motif) ligand 5		increases expression	ISO	17	34,198,495	34,207,377	RGD:6480464	CTD
G	CCL5	chemokine (C-C motif) ligand 5		increases expression	ISO	17	34,198,495	34,207,377	RGD:6480464	CTD
G	CD274	CD274 molecule		decreases expression	EXP	9	5,450,503	5,470,567	RGD:6480464	CTD
G	CD4	CD4 molecule		multiple interactions	EXP	12	6,898,638	6,929,976	RGD:6480464	CTD
G	CD40LG	CD40 ligand		multiple interactions	EXP	X	135,730,336	135,742,549	RGD:6480464	CTD
G	CD40LG	CD40 ligand		decreases response to substance	EXP	X	135,730,336	135,742,549	RGD:6480464	CTD
G	CD40LG	CD40 ligand		multiple interactions	ISO	X	135,730,336	135,742,549	RGD:6480464	CTD
G	CD44	CD44 molecule (Indian blood group)		decreases response to substance	EXP	11	35,160,417	35,253,949	RGD:6480464	CTD
G	CD44	CD44 molecule (Indian blood group)		decreases response to substance	EXP	11	35,160,417	35,253,949	RGD:6480464	CTD
G	CD44	CD44 molecule (Indian blood group)		increases expression	ISO	11	35,160,417	35,253,949	RGD:6480464	CTD
G	CD44	CD44 molecule (Indian blood group)		increases expression	EXP	11	35,160,417	35,253,949	RGD:6480464	CTD
G	CD44	CD44 molecule (Indian blood group)		increases expression	ISO	11	35,160,417	35,253,949	RGD:6480464	CTD
G	CD53	CD53 molecule		decreases expression	ISO	1	111,413,821	111,442,558	RGD:6480464	CTD
G	CD55	CD55 molecule, decay accelerating factor for complement (Cromer blood group)		affects response to substance	EXP	1	207,494,817	207,534,311	RGD:6480464	CTD
G	CD59	CD59 molecule, complement regulatory protein		multiple interactions	EXP	11	33,724,556	33,758,025	RGD:6480464	CTD
G	CD5L	CD5 molecule-like		decreases expression	ISO	1	157,800,704	157,811,634	RGD:6480464	CTD
G	CD68	CD68 molecule		increases expression	ISO	17	7,482,805	7,485,429	RGD:6480464	CTD
G	CD81	CD81 molecule		increases expression	ISO	11	2,398,547	2,418,649	RGD:6480464	CTD
G	CD9	CD9 molecule		increases expression	ISO	12	6,309,482	6,347,437	RGD:6480464	CTD
G	CDC20	cell division cycle 20		increases expression	ISO	1	43,824,626	43,828,874	RGD:6480464	CTD
G	CDC25A	cell division cycle 25A		increases phosphorylation	ISO	3	48,198,668	48,229,801	RGD:6480464	CTD
G	CDC25B	cell division cycle 25B		increases expression	ISO	20	3,776,401	3,786,762	RGD:6480464	CTD
G	CDC25B	cell division cycle 25B		decreases expression	ISO	20	3,776,401	3,786,762	RGD:6480464	CTD
G	CDC25C	cell division cycle 25C		increases expression	ISO	5	137,620,959	137,667,516	RGD:6480464	CTD
G	CDC37	cell division cycle 37		increases expression	ISO	19	10,501,809	10,514,271	RGD:6480464	CTD
G	CDC40	cell division cycle 40		increases expression	EXP	6	110,501,624	110,553,423	RGD:6480464	CTD
G	CDC42	cell division cycle 42		multiple interactions	EXP	1	22,379,120	22,419,436	RGD:6480464	CTD
G	CDC42	cell division cycle 42		decreases expression	ISO	1	22,379,120	22,419,436	RGD:6480464	CTD
G	CDC42EP3	CDC42 effector protein (Rho GTPase binding) 3		decreases expression	ISO	2	37,869,025	37,899,678	RGD:6480464	CTD
G	CDC42EP3	CDC42 effector protein (Rho GTPase binding) 3		increases expression	ISO	2	37,869,025	37,899,678	RGD:6480464	CTD
G	CDC6	cell division cycle 6		increases phosphorylation	ISO	17	38,444,146	38,459,413	RGD:6480464	CTD
G	CDCA2	cell division cycle associated 2		increases expression	ISO	8	25,316,513	25,365,425	RGD:6480464	CTD
G	CDCA3	cell division cycle associated 3		multiple interactions	EXP	12	6,957,972	6,960,456	RGD:6480464	CTD
G	CDCA3	cell division cycle associated 3		decreases expression	ISO	12	6,957,972	6,960,456	RGD:6480464	CTD
G	CDCA8	cell division cycle associated 8		multiple interactions	EXP	1	38,158,073	38,175,391	RGD:6480464	CTD
G	CDH1	cadherin 1, type 1, E-cadherin (epithelial)		multiple interactions	EXP	16	68,771,195	68,869,444	RGD:6480464	CTD
G	CDH1	cadherin 1, type 1, E-cadherin (epithelial)		multiple interactions	EXP	16	68,771,195	68,869,444	RGD:6480464	CTD
G	CDH1	cadherin 1, type 1, E-cadherin (epithelial)		decreases expression	EXP	16	68,771,195	68,869,444	RGD:6480464	CTD
G	CDH17	cadherin 17, LI cadherin (liver-intestine)		decreases expression	ISO	8	95,139,394	95,229,531	RGD:6480464	CTD
G	CDH2	cadherin 2, type 1, N-cadherin (neuronal)		increases expression	EXP	18	25,530,930	25,757,445	RGD:6480464	CTD
G	CDH3	cadherin 3, type 1, P-cadherin (placental)		affects response to substance	EXP	16	68,678,151	68,732,957	RGD:6480464	CTD
G	CDK1	cyclin-dependent kinase 1		decreases response to substance	EXP	10	62,538,089	62,554,610	RGD:6480464	CTD
G	CDK1	cyclin-dependent kinase 1		multiple interactions	EXP	10	62,538,089	62,554,610	RGD:6480464	CTD
G	CDK1	cyclin-dependent kinase 1		decreases expression	EXP	10	62,538,089	62,554,610	RGD:6480464	CTD
G	CDK1	cyclin-dependent kinase 1		multiple interactions	ISO	10	62,538,089	62,554,610	RGD:6480464	CTD
G	CDK1	cyclin-dependent kinase 1		increases phosphorylation	EXP	10	62,538,089	62,554,610	RGD:6480464	CTD
G	CDK1	cyclin-dependent kinase 1		increases expression	ISO	10	62,538,089	62,554,610	RGD:6480464	CTD
G	CDK12	cyclin-dependent kinase 12		increases expression	ISO	17	37,617,739	37,690,800	RGD:6480464	CTD
G	CDK14	cyclin-dependent kinase 14		decreases expression	ISO	7	90,338,712	90,839,904	RGD:6480464	CTD
G	CDK17	cyclin-dependent kinase 17		increases phosphorylation	ISO	12	96,672,039	96,794,366	RGD:6480464	CTD
G	CDK2	cyclin-dependent kinase 2		multiple interactions	EXP	12	56,360,556	56,366,568	RGD:6480464	CTD
G	CDK2	cyclin-dependent kinase 2		multiple interactions	EXP	12	56,360,556	56,366,568	RGD:6480464	CTD
G	CDK2	cyclin-dependent kinase 2		multiple interactions	EXP	12	56,360,556	56,366,568	RGD:6480464	CTD
G	CDK2	cyclin-dependent kinase 2		increases phosphorylation	EXP	12	56,360,556	56,366,568	RGD:6480464	CTD
G	CDK2	cyclin-dependent kinase 2		multiple interactions	ISO	12	56,360,556	56,366,568	RGD:6480464	CTD
G	CDK4	cyclin-dependent kinase 4		multiple interactions	EXP	12	58,141,510	58,146,230	RGD:6480464	CTD
G	CDK4	cyclin-dependent kinase 4		decreases expression	ISO	12	58,141,510	58,146,230	RGD:6480464	CTD
G	CDK7	cyclin-dependent kinase 7		decreases response to substance	ISO	5	68,530,622	68,573,257	RGD:6480464	CTD
G	CDKL5	cyclin-dependent kinase-like 5		increases expression	EXP	X	18,443,725	18,671,749	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		multiple interactions	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		multiple interactions	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		increases response to substance	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		increases response to substance	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		multiple interactions	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		multiple interactions	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		multiple interactions	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		multiple interactions	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		decreases expression	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		multiple interactions	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		multiple interactions	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		increases expression	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		increases expression	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		increases expression	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		increases phosphorylation	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		multiple interactions	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		multiple interactions	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		multiple interactions	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		multiple interactions	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		decreases response to substance	ISO	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		multiple interactions	ISO	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		increases expression	ISO	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		increases expression	ISO	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)		decreases response to substance	EXP	12	12,870,302	12,875,305	RGD:6480464	CTD
G	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)		multiple interactions	EXP	12	12,870,302	12,875,305	RGD:6480464	CTD
G	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)		multiple interactions	EXP	12	12,870,302	12,875,305	RGD:6480464	CTD
G	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)		increases expression	EXP	12	12,870,302	12,875,305	RGD:6480464	CTD
G	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)		increases expression	EXP	12	12,870,302	12,875,305	RGD:6480464	CTD
G	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)		decreases expression	ISO	12	12,870,302	12,875,305	RGD:6480464	CTD
G	CDKN2A	cyclin-dependent kinase inhibitor 2A		decreases expression	EXP	9	21,967,751	21,994,490	RGD:6480464	CTD
G	CDKN2A	cyclin-dependent kinase inhibitor 2A		increases expression	EXP	9	21,967,751	21,994,490	RGD:6480464	CTD
G	CDKN2AIP	CDKN2A interacting protein		affects response to substance	EXP	4	184,365,789	184,369,049	RGD:6480464	CTD
G	CDKN3	cyclin-dependent kinase inhibitor 3		multiple interactions	EXP	14	54,863,673	54,886,936	RGD:6480464	CTD
G	CDO1	cysteine dioxygenase, type I		decreases expression	ISO	5	115,140,430	115,152,405	RGD:6480464	CTD
G	CEBPB	CCAAT/enhancer binding protein (C/EBP), beta		decreases expression	ISO	20	48,807,120	48,809,227	RGD:6480464	CTD
G	CEBPB	CCAAT/enhancer binding protein (C/EBP), beta		multiple interactions	EXP	20	48,807,120	48,809,227	RGD:6480464	CTD
G	CEBPD	CCAAT/enhancer binding protein (C/EBP), delta		affects expression	ISO	8	48,649,476	48,650,726	RGD:6480464	CTD
G	CEBPG	CCAAT/enhancer binding protein (C/EBP), gamma		multiple interactions	EXP	19	33,864,575	33,873,592	RGD:6480464	CTD
G	CELSR2	cadherin, EGF LAG seven-pass G-type receptor 2		affects response to substance	EXP	1	109,792,641	109,818,378	RGD:6480464	CTD
G	CENPA	centromere protein A		multiple interactions	EXP	2	27,008,882	27,017,457	RGD:6480464	CTD
G	CERS4	ceramide synthase 4		affects response to substance	EXP	19	8,274,217	8,327,305	RGD:6480464	CTD
G	CES2	carboxylesterase 2		affects response to substance	EXP	16	66,968,347	66,978,999	RGD:6480464	CTD
G	CILP	cartilage intermediate layer protein, nucleotide pyrophosphohydrolase		affects response to substance	EXP	15	65,488,337	65,503,840	RGD:6480464	CTD
G	CISH	cytokine inducible SH2-containing protein		decreases expression	ISO	3	50,643,885	50,649,262	RGD:6480464	CTD
G	CITED2	Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2		increases expression	EXP	6	139,693,392	139,695,787	RGD:6480464	CTD
G	CITED2	Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2		multiple interactions	EXP	6	139,693,392	139,695,787	RGD:6480464	CTD
G	CITED2	Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2		decreases response to substance	EXP	6	139,693,392	139,695,787	RGD:6480464	CTD
G	CITED2	Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2		increases expression	ISO	6	139,693,392	139,695,787	RGD:6480464	CTD
G	CIZ1	CDKN1A interacting zinc finger protein 1		multiple interactions	EXP	9	130,928,344	130,966,662	RGD:6480464	CTD
G	CKAP2	cytoskeleton associated protein 2		increases expression	ISO	13	53,029,495	53,050,763	RGD:6480464	CTD
G	CKMT1B	creatine kinase, mitochondrial 1B		affects response to substance	EXP	15	43,885,252	43,891,604	RGD:6480464	CTD
G	CKS2	CDC28 protein kinase regulatory subunit 2		multiple interactions	EXP	9	91,926,113	91,931,618	RGD:6480464	CTD
G	CLCN3	chloride channel, voltage-sensitive 3		multiple interactions	EXP	4	170,541,672	170,644,338	RGD:6480464	CTD
G	CLCN4	chloride channel, voltage-sensitive 4		decreases expression	ISO	X	10,124,985	10,205,700	RGD:6480464	CTD
G	CLDN2	claudin 2		decreases expression	ISO	X	106,143,394	106,174,091	RGD:6480464	CTD
G	CLDN7	claudin 7		decreases response to substance	EXP	17	7,163,222	7,166,512	RGD:6480464	CTD
G	CLIP2	CAP-GLY domain containing linker protein 2		decreases expression	EXP	7	73,703,805	73,820,273	RGD:6480464	CTD
G	CLOCK	clock circadian regulator		decreases expression	EXP	4	56,294,068	56,413,076	RGD:6480464	CTD
G	CLU	clusterin		decreases response to substance	EXP	8	27,454,434	27,472,328	RGD:6480464	CTD
G	CLU	clusterin		increases expression	ISO	8	27,454,434	27,472,328	RGD:6480464	CTD
G	CLU	clusterin		decreases expression	ISO	8	27,454,434	27,472,328	RGD:6480464	CTD
G	CLU	clusterin		increases expression	ISO	8	27,454,434	27,472,328	RGD:6480464	CTD
G	CLU	clusterin		decreases expression	ISO	8	27,454,434	27,472,328	RGD:6480464	CTD
G	CLU	clusterin		increases expression	ISO	8	27,454,434	27,472,328	RGD:6480464	CTD
G	CMTM3	CKLF-like MARVEL transmembrane domain containing 3		decreases expression	ISO	16	66,637,935	66,647,795	RGD:6480464	CTD
G	CNN1	calponin 1, basic, smooth muscle		decreases expression	ISO	19	11,649,579	11,661,138	RGD:6480464	CTD
G	CNN2	calponin 2		increases expression	ISO	19	1,026,298	1,039,064	RGD:6480464	CTD
G	CNN3	calponin 3, acidic		multiple interactions	EXP	1	95,362,507	95,392,735	RGD:6480464	CTD
G	CNP	2',3'-cyclic nucleotide 3' phosphodiesterase		increases expression	ISO	17	40,118,759	40,129,754	RGD:6480464	CTD
G	CNTF	ciliary neurotrophic factor		multiple interactions	EXP	11	58,390,146	58,393,206	RGD:6480464	CTD
G	CNTNAP2	contactin associated protein-like 2		affects response to substance	EXP	7	145,813,453	148,118,090	RGD:6480464	CTD
G	COL11A2	collagen, type XI, alpha 2		affects response to substance	EXP	6	33,130,469	33,160,245	RGD:6480464	CTD
G	COL4A5	collagen, type IV, alpha 5		affects response to substance	EXP	X	107,683,074	107,940,775	RGD:6480464	CTD
G	COMT	catechol-O-methyltransferase		increases expression	ISO	22	19,929,263	19,957,498	RGD:6480464	CTD
G	COPS5	COP9 signalosome subunit 5		increases response to substance	EXP	8	67,955,314	67,974,562	RGD:6480464	CTD
G	CORO1C	coronin, actin binding protein, 1C		affects response to substance	EXP	12	109,038,885	109,125,295	RGD:6480464	CTD
G	COTL1	coactosin-like 1 (Dictyostelium)		decreases expression	ISO	16	84,599,202	84,651,669	RGD:6480464	CTD
G	COX5B	cytochrome c oxidase subunit Vb		increases expression	ISO	2	98,262,521	98,264,657	RGD:6480464	CTD
G	COX6A1	cytochrome c oxidase subunit VIa polypeptide 1		increases expression	ISO	12	120,875,893	120,878,545	RGD:6480464	CTD
G	COX6A2	cytochrome c oxidase subunit VIa polypeptide 2		decreases expression	ISO	16	31,439,052	31,439,749	RGD:6480464	CTD
G	COX7A1	cytochrome c oxidase subunit VIIa polypeptide 1 (muscle)		increases expression	ISO	19	36,641,824	36,643,771	RGD:6480464	CTD
G	COX8A	cytochrome c oxidase subunit VIIIA (ubiquitous)		increases expression	ISO	11	63,742,079	63,744,015	RGD:6480464	CTD
G	CP	ceruloplasmin (ferroxidase)		increases expression	ISO	3	148,880,197	148,939,832	RGD:6480464	CTD
G	CPE	carboxypeptidase E		decreases expression	ISO	4	166,300,097	166,419,482	RGD:6480464	CTD
G	CPSF1	cleavage and polyadenylation specific factor 1, 160kDa		multiple interactions	EXP	8	145,618,446	145,634,733	RGD:6480464	CTD
G	CRADD	CASP2 and RIPK1 domain containing adaptor with death domain		decreases expression	ISO	12	94,071,151	94,244,532	RGD:6480464	CTD
G	CRCT1	cysteine-rich C-terminal 1		decreases expression	ISO	1	152,486,978	152,488,481	RGD:6480464	CTD
G	CREB3L1	cAMP responsive element binding protein 3-like 1		increases expression	ISO	11	46,299,228	46,342,972	RGD:6480464	CTD
G	CREBBP	CREB binding protein		decreases expression	EXP	16	3,775,055	3,930,121	RGD:6480464	CTD
G	CREG1	cellular repressor of E1A-stimulated genes 1		increases expression	ISO	1	167,510,250	167,523,056	RGD:6480464	CTD
G	CRK	v-crk sarcoma virus CT10 oncogene homolog (avian)		multiple interactions	EXP	17	1,324,647	1,359,561	RGD:6480464	CTD
G	CRK	v-crk sarcoma virus CT10 oncogene homolog (avian)		increases expression	ISO	17	1,324,647	1,359,561	RGD:6480464	CTD
G	CRMP1	collapsin response mediator protein 1		increases phosphorylation	ISO	4	5,822,491	5,894,785	RGD:6480464	CTD
G	CRYAB	crystallin, alpha B		increases expression	ISO	11	111,779,350	111,782,473	RGD:6480464	CTD
G	CSF1	colony stimulating factor 1 (macrophage)		increases expression	ISO	1	110,453,233	110,473,616	RGD:6480464	CTD
G	CSF2	colony stimulating factor 2 (granulocyte-macrophage)		increases expression	ISO	5	131,409,485	131,411,863	RGD:6480464	CTD
G	CSF3	colony stimulating factor 3 (granulocyte)		increases expression	ISO	17	38,171,614	38,174,066	RGD:6480464	CTD
G	CSNK1A1	casein kinase 1, alpha 1		multiple interactions	EXP	5	148,874,845	148,931,007	RGD:6480464	CTD
G	CSNK2A1	casein kinase 2, alpha 1 polypeptide		decreases expression	ISO	20	463,338	524,482	RGD:6480464	CTD
G	CSNK2A2	casein kinase 2, alpha prime polypeptide		multiple interactions	EXP	16	58,191,811	58,231,782	RGD:6480464	CTD
G	CSPP1	centrosome and spindle pole associated protein 1		increases response to substance	EXP	8	67,976,603	68,108,849	RGD:6480464	CTD
G	CTAGE4	CTAGE family, member 4		affects response to substance	EXP	7	143,880,548	143,883,173	RGD:6480464	CTD
G	CTCFL	CCCTC-binding factor (zinc finger protein)-like		decreases expression	ISO	20	56,071,021	56,100,708	RGD:6480464	CTD
G	CTDSP1	CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1		decreases response to substance	EXP	2	219,263,061	219,270,664	RGD:6480464	CTD
G	CTGF	connective tissue growth factor		increases expression	ISO	6	132,269,316	132,272,518	RGD:6480464	CTD
G	CTH	cystathionase (cystathionine gamma-lyase)		increases expression	ISO	1	70,876,901	70,905,534	RGD:6480464	CTD
G	CTH	cystathionase (cystathionine gamma-lyase)		affects response to substance	EXP	1	70,876,901	70,905,534	RGD:6480464	CTD
G	CTNNA1	catenin (cadherin-associated protein), alpha 1, 102kDa		decreases expression	ISO	5	138,089,107	138,270,723	RGD:6480464	CTD
G	CTNNAL1	catenin (cadherin-associated protein), alpha-like 1		affects response to substance	EXP	9	111,704,851	111,775,764	RGD:6480464	CTD
G	CTNNB1	catenin (cadherin-associated protein), beta 1, 88kDa		decreases response to substance	EXP	3	41,240,942	41,281,939	RGD:6480464	CTD
G	CTNNB1	catenin (cadherin-associated protein), beta 1, 88kDa		multiple interactions	ISO	3	41,240,942	41,281,939	RGD:6480464	CTD
G	CTNNB1	catenin (cadherin-associated protein), beta 1, 88kDa		decreases localization	ISO	3	41,240,942	41,281,939	RGD:6480464	CTD
G	CTNNB1	catenin (cadherin-associated protein), beta 1, 88kDa		increases expression	EXP	3	41,240,942	41,281,939	RGD:6480464	CTD
G	CTSB	cathepsin B		increases expression	ISO	8	11,700,033	11,725,646	RGD:6480464	CTD
G	CTSB	cathepsin B		decreases expression	ISO	8	11,700,033	11,725,646	RGD:6480464	CTD
G	CTSD	cathepsin D		increases expression	ISO	11	1,773,982	1,785,222	RGD:6480464	CTD
G	CTTN	cortactin		increases expression	ISO	11	70,244,612	70,282,690	RGD:6480464	CTD
G	CUL5	cullin 5		increases expression	ISO	11	107,879,408	107,978,488	RGD:6480464	CTD
G	CUX1	cut-like homeobox 1		decreases expression	ISO	7	101,459,184	101,927,250	RGD:6480464	CTD
G	CXCL1	chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)		multiple interactions	EXP	4	74,735,109	74,737,019	RGD:6480464	CTD
G	CXCL1	chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)		increases expression	ISO	4	74,735,109	74,737,019	RGD:6480464	CTD
G	CXCL10	chemokine (C-X-C motif) ligand 10		increases expression	ISO	4	76,942,269	76,944,689	RGD:6480464	CTD
G	CXCL10	chemokine (C-X-C motif) ligand 10		increases expression	ISO	4	76,942,269	76,944,689	RGD:6480464	CTD
G	CXCL11	chemokine (C-X-C motif) ligand 11		increases expression	ISO	4	76,954,835	76,957,350	RGD:6480464	CTD
G	CXCL12	chemokine (C-X-C motif) ligand 12		decreases expression	ISO	10	44,865,605	44,880,545	RGD:6480464	CTD
G	CXCL2	chemokine (C-X-C motif) ligand 2		multiple interactions	EXP	4	74,962,752	74,964,997	RGD:6480464	CTD
G	CXCL2	chemokine (C-X-C motif) ligand 2		increases response to substance	EXP	4	74,962,752	74,964,997	RGD:6480464	CTD
G	CXCL2	chemokine (C-X-C motif) ligand 2		affects expression	ISO	4	74,962,752	74,964,997	RGD:6480464	CTD
G	CXCL2	chemokine (C-X-C motif) ligand 2		increases expression	ISO	4	74,962,752	74,964,997	RGD:6480464	CTD
G	CXCL2	chemokine (C-X-C motif) ligand 2		increases expression	ISO	4	74,962,752	74,964,997	RGD:6480464	CTD
G	CXCL2	chemokine (C-X-C motif) ligand 2		multiple interactions	ISO	4	74,962,752	74,964,997	RGD:6480464	CTD
G	CXCR4	chemokine (C-X-C motif) receptor 4		multiple interactions	EXP	2	136,871,919	136,875,725	RGD:6480464	CTD
G	CXCR7	chemokine (C-X-C motif) receptor 7		affects expression	ISO	2	237,478,380	237,490,997	RGD:6480464	CTD
G	CYB5A	cytochrome b5 type A (microsomal)		decreases expression	ISO	18	71,920,527	71,959,251	RGD:6480464	CTD
G	CYB5R3	cytochrome b5 reductase 3		decreases expression	ISO	22	43,013,846	43,045,405	RGD:6480464	CTD
G	CYB5R3	cytochrome b5 reductase 3		increases expression	ISO	22	43,013,846	43,045,405	RGD:6480464	CTD
G	CYBA	cytochrome b-245, alpha polypeptide		increases expression	ISO	16	88,709,697	88,717,492	RGD:6480464	CTD
G	CYCS	cytochrome c, somatic		affects localization	EXP	7	25,158,270	25,164,980	RGD:6480464	CTD
G	CYCS	cytochrome c, somatic		increases expression	ISO	7	25,158,270	25,164,980	RGD:6480464	CTD
G	CYFIP2	cytoplasmic FMR1 interacting protein 2		multiple interactions	EXP	5	156,693,091	156,822,606	RGD:6480464	CTD
G	CYLD	cylindromatosis (turban tumor syndrome)		increases response to substance	EXP	16	50,775,961	50,835,846	RGD:6480464	CTD
G	CYMP	chymosin pseudogene		increases expression	ISO	1	111,023,388	111,033,891	RGD:6480464	CTD
G	DDIT3	DNA-damage-inducible transcript 3		increases expression	EXP	12	57,910,371	57,914,300	RGD:6480464	CTD
G	DDIT3	DNA-damage-inducible transcript 3		multiple interactions	ISO	12	57,910,371	57,914,300	RGD:6480464	CTD
G	DDIT3	DNA-damage-inducible transcript 3		increases expression	ISO	12	57,910,371	57,914,300	RGD:6480464	CTD
G	DDIT3	DNA-damage-inducible transcript 3		increases expression	ISO	12	57,910,371	57,914,300	RGD:6480464	CTD
G	DDIT4	DNA-damage-inducible transcript 4		increases expression	EXP	10	74,033,677	74,035,797	RGD:6480464	CTD
G	DDIT4	DNA-damage-inducible transcript 4		increases expression	EXP	10	74,033,677	74,035,797	RGD:6480464	CTD
G	DDIT4	DNA-damage-inducible transcript 4		increases expression	ISO	10	74,033,677	74,035,797	RGD:6480464	CTD
G	DDIT4L	DNA-damage-inducible transcript 4-like		increases expression	ISO	4	101,107,027	101,111,655	RGD:6480464	CTD
G	DDR1	discoidin domain receptor tyrosine kinase 1		affects response to substance	EXP	6	30,851,861	30,867,933	RGD:6480464	CTD
G	DDR1	discoidin domain receptor tyrosine kinase 1		increases expression	ISO	6	30,851,861	30,867,933	RGD:6480464	CTD
G	DDX5	DEAD (Asp-Glu-Ala-Asp) box helicase 5		decreases expression	ISO	17	62,494,374	62,502,484	RGD:6480464	CTD
G	DDX58	DEAD (Asp-Glu-Ala-Asp) box polypeptide 58		increases expression	ISO	9	32,455,300	32,526,322	RGD:6480464	CTD
G	DECR1	2,4-dienoyl CoA reductase 1, mitochondrial		increases expression	ISO	8	91,013,580	91,064,227	RGD:6480464	CTD
G	DEK	DEK oncogene		increases phosphorylation	ISO	6	18,224,400	18,264,799	RGD:6480464	CTD
G	DEK	DEK oncogene		decreases response to substance	EXP	6	18,224,400	18,264,799	RGD:6480464	CTD
G	DENND4A	DENN/MADD domain containing 4A		decreases response to substance	EXP	15	65,952,954	66,084,631	RGD:6480464	CTD
G	DEPTOR	DEP domain containing MTOR-interacting protein		affects response to substance	EXP	8	120,885,900	121,063,157	RGD:6480464	CTD
G	DHCR24	24-dehydrocholesterol reductase		increases expression	ISO	1	55,315,300	55,352,921	RGD:6480464	CTD
G	DHFR	dihydrofolate reductase		multiple interactions	EXP	5	79,922,045	79,950,800	RGD:6480464	CTD
G	DIABLO	diablo, IAP-binding mitochondrial protein		increases response to substance	EXP	12	122,692,209	122,712,068	RGD:6480464	CTD
G	DIAPH3	diaphanous homolog 3 (Drosophila)		decreases expression	ISO	13	60,239,717	60,738,119	RGD:6480464	CTD
G	DICER1	dicer 1, ribonuclease type III		increases expression	EXP	14	95,552,565	95,623,759	RGD:6480464	CTD
G	DICER1	dicer 1, ribonuclease type III		multiple interactions	EXP	14	95,552,565	95,623,759	RGD:6480464	CTD
G	DICER1	dicer 1, ribonuclease type III		increases response to substance	EXP	14	95,552,565	95,623,759	RGD:6480464	CTD
G	DIO3	deiodinase, iodothyronine, type III		decreases expression	ISO	14	102,027,688	102,029,789	RGD:6480464	CTD
G	DIS3L2	DIS3 mitotic control homolog (S. cerevisiae)-like 2		decreases expression	ISO	2	232,826,293	233,208,678	RGD:6480464	CTD
G	DKC1	dyskeratosis congenita 1, dyskerin		increases phosphorylation	ISO	X	153,991,031	154,005,964	RGD:6480464	CTD
G	DKK1	dickkopf 1 homolog (Xenopus laevis)		affects response to substance	EXP	10	54,074,041	54,077,417	RGD:6480464	CTD
G	DKK3	dickkopf 3 homolog (Xenopus laevis)		affects expression	ISO	11	11,984,543	12,030,917	RGD:6480464	CTD
G	DLGAP5	discs, large (Drosophila) homolog-associated protein 5		multiple interactions	EXP	14	55,614,834	55,658,396	RGD:6480464	CTD
G	DLX2	distal-less homeobox 2		decreases expression	ISO	2	172,964,166	172,967,478	RGD:6480464	CTD
G	DMBT1	deleted in malignant brain tumors 1		affects response to substance	EXP	10	124,320,181	124,403,252	RGD:6480464	CTD
G	DNAJA1	DnaJ (Hsp40) homolog, subfamily A, member 1		multiple interactions	EXP	9	33,025,209	33,039,062	RGD:6480464	CTD
G	DNAJB12	DnaJ (Hsp40) homolog, subfamily B, member 12		multiple interactions	EXP	10	74,092,588	74,114,907	RGD:6480464	CTD
G	DNAJC9	DnaJ (Hsp40) homolog, subfamily C, member 9		multiple interactions	EXP	10	75,002,582	75,007,025	RGD:6480464	CTD
G	DNM1L	dynamin 1-like		increases response to substance	EXP	12	32,832,137	32,898,584	RGD:6480464	CTD
G	DNM1L	dynamin 1-like		increases expression	ISO	12	32,832,137	32,898,584	RGD:6480464	CTD
G	DNMT1	DNA (cytosine-5-)-methyltransferase 1		decreases response to substance	EXP	19	10,244,022	10,305,755	RGD:6480464	CTD
G	DNMT1	DNA (cytosine-5-)-methyltransferase 1		decreases response to substance	ISO	19	10,244,022	10,305,755	RGD:6480464	CTD
G	DNMT3B	DNA (cytosine-5-)-methyltransferase 3 beta		decreases response to substance	EXP	20	31,350,191	31,397,162	RGD:6480464	CTD
G	DNMT3B	DNA (cytosine-5-)-methyltransferase 3 beta		increases phosphorylation	ISO	20	31,350,191	31,397,162	RGD:6480464	CTD
G	DOCK1	dedicator of cytokinesis 1		decreases expression	ISO	10	128,768,965	129,250,780	RGD:6480464	CTD
G	DOK1	docking protein 1, 62kDa (downstream of tyrosine kinase 1)		increases response to substance	EXP	2	74,776,147	74,784,678	RGD:6480464	CTD
G	DONSON	downstream neighbor of SON		multiple interactions	EXP	21	34,949,857	34,961,014	RGD:6480464	CTD
G	DPM1	dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunit		multiple interactions	EXP	20	49,551,405	49,575,060	RGD:6480464	CTD
G	DPP3	dipeptidyl-peptidase 3		multiple interactions	EXP	11	66,247,484	66,277,130	RGD:6480464	CTD
G	DPYD	dihydropyrimidine dehydrogenase		multiple interactions	EXP	1	97,543,299	98,386,615	RGD:6480464	CTD
G	DPYD	dihydropyrimidine dehydrogenase		multiple interactions	EXP	1	97,543,299	98,386,615	RGD:6480464	CTD
G	DPYD	dihydropyrimidine dehydrogenase		decreases activity	EXP	1	97,543,299	98,386,615	RGD:6480464	CTD
G	DPYD	dihydropyrimidine dehydrogenase		decreases expression	EXP	1	97,543,299	98,386,615	RGD:6480464	CTD
G	DPYD	dihydropyrimidine dehydrogenase		multiple interactions	EXP	1	97,543,299	98,386,615	RGD:6480464	CTD
G	DPYD	dihydropyrimidine dehydrogenase		multiple interactions	EXP	1	97,543,299	98,386,615	RGD:6480464	CTD
G	DPYD	dihydropyrimidine dehydrogenase		affects response to substance	EXP	1	97,543,299	98,386,615	RGD:6480464	CTD
G	DPYD	dihydropyrimidine dehydrogenase		multiple interactions	EXP	1	97,543,299	98,386,615	RGD:6480464	CTD
G	DPYD	dihydropyrimidine dehydrogenase		decreases expression	ISO	1	97,543,299	98,386,615	RGD:6480464	CTD
G	DRAP1	DR1-associated protein 1 (negative cofactor 2 alpha)		affects response to substance	EXP	11	65,686,728	65,689,048	RGD:6480464	CTD
G	DSCC1	defective in sister chromatid cohesion 1 homolog (S. cerevisiae)		decreases expression	ISO	8	120,846,181	120,868,170	RGD:6480464	CTD
G	DSN1	DSN1, MIND kinetochore complex component, homolog (S. cerevisiae)		increases phosphorylation	ISO	20	35,380,194	35,402,230	RGD:6480464	CTD
G	DSPP	dentin sialophosphoprotein		decreases response to substance	EXP	4	88,529,681	88,538,025	RGD:6480464	CTD
G	DST	dystonin		affects response to substance	EXP	6 6 6	56,322,785 56,535,286 56,713,863	56,507,694 56,708,082 56,820,047	RGD:6480464	CTD
G	DTNA	dystrobrevin, alpha		decreases expression	ISO	18	32,073,254	32,471,808	RGD:6480464	CTD
G	DTYMK	deoxythymidylate kinase (thymidylate kinase)		multiple interactions	EXP	2	242,615,157	242,626,383	RGD:6480464	CTD
G	DUSP1	dual specificity phosphatase 1		increases expression	EXP	5	172,195,093	172,198,203	RGD:6480464	CTD
G	DUSP1	dual specificity phosphatase 1		multiple interactions	EXP	5	172,195,093	172,198,203	RGD:6480464	CTD
G	DUSP1	dual specificity phosphatase 1		decreases expression	ISO	5	172,195,093	172,198,203	RGD:6480464	CTD
G	DUSP14	dual specificity phosphatase 14		increases expression	EXP	17	35,849,951	35,873,588	RGD:6480464	CTD
G	DUSP14	dual specificity phosphatase 14		increases expression	ISO	17	35,849,951	35,873,588	RGD:6480464	CTD
G	DUSP22	dual specificity phosphatase 22		increases expression	ISO	6	292,101	351,355	RGD:6480464	CTD
G	DUSP23	dual specificity phosphatase 23		multiple interactions	EXP	1	159,750,759	159,752,333	RGD:6480464	CTD
G	DUSP6	dual specificity phosphatase 6		decreases expression	EXP	12	89,741,837	89,746,296	RGD:6480464	CTD
G	DUSP6	dual specificity phosphatase 6		multiple interactions	EXP	12	89,741,837	89,746,296	RGD:6480464	CTD
G	DUSP6	dual specificity phosphatase 6		decreases response to substance	EXP	12	89,741,837	89,746,296	RGD:6480464	CTD
G	DUSP6	dual specificity phosphatase 6		decreases expression	ISO	12	89,741,837	89,746,296	RGD:6480464	CTD
G	DUSP6	dual specificity phosphatase 6		increases response to substance	EXP	12	89,741,837	89,746,296	RGD:6480464	CTD
G	DUT	deoxyuridine triphosphatase		multiple interactions	EXP	15	48,623,621	48,635,570	RGD:6480464	CTD
G	DYNC1H1	dynein, cytoplasmic 1, heavy chain 1		multiple interactions	EXP	14	102,430,865	102,517,135	RGD:6480464	CTD
G	DYRK2	dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2		increases expression	EXP	12	68,042,512	68,056,444	RGD:6480464	CTD
G	DYSF	dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive)		decreases expression	ISO	2	71,680,753	71,913,893	RGD:6480464	CTD
G	DZIP1L	DAZ interacting protein 1-like		decreases expression	ISO	3	137,780,827	137,834,451	RGD:6480464	CTD
G	E2F1	E2F transcription factor 1		increases expression	EXP	20	32,263,292	32,274,210	RGD:6480464	CTD
G	E2F1	E2F transcription factor 1		increases acetylation	EXP	20	32,263,292	32,274,210	RGD:6480464	CTD
G	E2F3	E2F transcription factor 3		decreases expression	EXP	6	20,402,137	20,493,945	RGD:6480464	CTD
G	ECH1	enoyl CoA hydratase 1, peroxisomal		increases expression	ISO	19	39,306,062	39,322,497	RGD:6480464	CTD
G	ECHS1	enoyl CoA hydratase, short chain, 1, mitochondrial		increases expression	ISO	10	135,175,987	135,186,908	RGD:6480464	CTD
G	ECI1	enoyl-CoA delta isomerase 1		increases expression	ISO	16	2,289,873	2,301,602	RGD:6480464	CTD
G	ECT2	epithelial cell transforming sequence 2 oncogene		multiple interactions	EXP	3	172,468,475	172,539,264	RGD:6480464	CTD
G	ECT2	epithelial cell transforming sequence 2 oncogene		decreases expression	ISO	3	172,468,475	172,539,264	RGD:6480464	CTD
G	EDA2R	ectodysplasin A2 receptor		increases expression	ISO	X	65,815,479	65,859,140	RGD:6480464	CTD
G	EDN1	endothelin 1		increases expression	EXP	6	12,290,529	12,297,427	RGD:6480464	CTD
G	EDN1	endothelin 1		multiple interactions	EXP	6	12,290,529	12,297,427	RGD:6480464	CTD
G	EDN1	endothelin 1		decreases expression	ISO	6	12,290,529	12,297,427	RGD:6480464	CTD
G	EDN1	endothelin 1		decreases response to substance	EXP	6	12,290,529	12,297,427	RGD:6480464	CTD
G	EDN2	endothelin 2		multiple interactions	EXP	1	41,944,446	41,950,344	RGD:6480464	CTD
G	EDNRA	endothelin receptor type A		affects response to substance	EXP	4	148,402,069	148,466,106	RGD:6480464	CTD
G	EEF1D	eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein)		decreases expression	ISO	8	144,661,867	144,679,845	RGD:6480464	CTD
G	EEF2	eukaryotic translation elongation factor 2		decreases response to substance	EXP	19	3,976,054	3,985,461	RGD:6480464	CTD
G	EFEMP2	EGF containing fibulin-like extracellular matrix protein 2		decreases expression	ISO	11	65,633,912	65,640,405	RGD:6480464	CTD
G	EGF	epidermal growth factor		multiple interactions	EXP	4	110,834,040	110,934,118	RGD:6480464	CTD
G	EGF	epidermal growth factor		decreases expression	ISO	4	110,834,040	110,934,118	RGD:6480464	CTD
G	EGF	epidermal growth factor		decreases expression	ISO	4	110,834,040	110,934,118	RGD:6480464	CTD
G	EGFR	epidermal growth factor receptor		multiple interactions	EXP	7	55,086,725	55,275,031	RGD:6480464	CTD
G	EIF4EBP1	eukaryotic translation initiation factor 4E binding protein 1		multiple interactions	EXP	8	37,888,020	37,917,883	RGD:6480464	CTD
G	EIF4EBP2	eukaryotic translation initiation factor 4E binding protein 2		decreases phosphorylation	ISO	10	72,163,861	72,188,374	RGD:6480464	CTD
G	EIF5B	eukaryotic translation initiation factor 5B		multiple interactions	EXP	2	99,953,834	100,016,728	RGD:6480464	CTD
G	ELF2	E74-like factor 2 (ets domain transcription factor)		increases phosphorylation	ISO	4	139,978,871	140,060,606	RGD:6480464	CTD
G	ELK3	ELK3, ETS-domain protein (SRF accessory protein 2)		decreases expression	ISO	12	96,588,207	96,661,606	RGD:6480464	CTD
G	ELMO2	engulfment and cell motility 2		increases expression	EXP	20	44,994,689	45,035,271	RGD:6480464	CTD
G	EMILIN2	elastin microfibril interfacer 2		increases expression	ISO	18	2,847,028	2,914,090	RGD:6480464	CTD
G	EMP1	epithelial membrane protein 1		decreases expression	ISO	12	13,349,602	13,369,708	RGD:6480464	CTD
G	EMP1	epithelial membrane protein 1		increases expression	ISO	12	13,349,602	13,369,708	RGD:6480464	CTD
G	EMP3	epithelial membrane protein 3		increases expression	EXP	19	48,828,629	48,833,810	RGD:6480464	CTD
G	EMP3	epithelial membrane protein 3		affects response to substance	EXP	19	48,828,629	48,833,810	RGD:6480464	CTD
G	EMP3	epithelial membrane protein 3		increases expression	ISO	19	48,828,629	48,833,810	RGD:6480464	CTD
G	EMX2	empty spiracles homeobox 2		increases response to substance	EXP	10	119,301,956	119,309,057	RGD:6480464	CTD
G	ENO2	enolase 2 (gamma, neuronal)		decreases expression	ISO	12	7,023,614	7,032,859	RGD:6480464	CTD
G	ENPP2	ectonucleotide pyrophosphatase/phosphodiesterase 2		affects response to substance	EXP	8	120,569,317	120,651,106	RGD:6480464	CTD
G	ENSA	endosulfine alpha		increases phosphorylation	ISO	1	150,594,599	150,602,098	RGD:6480464	CTD
G	ENTPD6	ectonucleoside triphosphate diphosphohydrolase 6 (putative)		multiple interactions	EXP	20	25,176,339	25,207,360	RGD:6480464	CTD
G	EOMES	eomesodermin		decreases expression	ISO	3	27,757,868	27,763,785	RGD:6480464	CTD
G	EP300	E1A binding protein p300		multiple interactions	EXP	22	41,488,614	41,576,081	RGD:6480464	CTD
G	EP300	E1A binding protein p300		decreases expression	EXP	22	41,488,614	41,576,081	RGD:6480464	CTD
G	EP300	E1A binding protein p300		multiple interactions	ISO	22	41,488,614	41,576,081	RGD:6480464	CTD
G	EP300	E1A binding protein p300		increases expression	ISO	22	41,488,614	41,576,081	RGD:6480464	CTD
G	EPB41L2	erythrocyte membrane protein band 4.1-like 2		multiple interactions	EXP	6	131,160,487	131,384,462	RGD:6480464	CTD
G	EPB41L5	erythrocyte membrane protein band 4.1 like 5		increases phosphorylation	ISO	2	120,770,604	120,936,697	RGD:6480464	CTD
G	EPCAM	epithelial cell adhesion molecule		increases expression	EXP	2	47,596,287	47,614,167	RGD:6480464	CTD
G	EPHA4	EPH receptor A4		decreases expression	ISO	2	222,282,747	222,437,010	RGD:6480464	CTD
G	EPHX1	epoxide hydrolase 1, microsomal (xenobiotic)		increases expression	ISO	1	225,997,797	226,033,264	RGD:6480464	CTD
G	EPHX1	epoxide hydrolase 1, microsomal (xenobiotic)		increases expression	ISO	1	225,997,797	226,033,264	RGD:6480464	CTD
G	EPHX1	epoxide hydrolase 1, microsomal (xenobiotic)		affects expression	ISO	1	225,997,797	226,033,264	RGD:6480464	CTD
G	EPO	erythropoietin		increases expression	ISO	7	100,318,423	100,321,323	RGD:6480464	CTD
G	EPO	erythropoietin		decreases response to substance	ISO	7	100,318,423	100,321,323	RGD:6480464	CTD
G	EPO	erythropoietin		affects expression	ISO	7	100,318,423	100,321,323	RGD:6480464	CTD
G	ERBB2	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)		multiple interactions	EXP	17	37,844,393	37,884,915	RGD:6480464	CTD
G	ERBB2	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)		multiple interactions	EXP	17	37,844,393	37,884,915	RGD:6480464	CTD
G	ERBB2	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)		decreases response to substance	EXP	17	37,844,393	37,884,915	RGD:6480464	CTD
G	ERBB2	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)		decreases response to substance	EXP	17	37,844,393	37,884,915	RGD:6480464	CTD
G	ERBB2	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)		affects response to substance	EXP	17	37,844,393	37,884,915	RGD:6480464	CTD
G	ERCC1	excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)		affects expression	EXP	19	45,910,591	45,927,177	RGD:6480464	CTD
G	ERCC1	excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)		multiple interactions	EXP	19	45,910,591	45,927,177	RGD:6480464	CTD
G	ERCC1	excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)		multiple interactions	EXP	19	45,910,591	45,927,177	RGD:6480464	CTD
G	ERCC1	excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)		increases expression	EXP	19	45,910,591	45,927,177	RGD:6480464	CTD
G	ERCC1	excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)		increases expression	EXP	19	45,910,591	45,927,177	RGD:6480464	CTD
G	ERCC1	excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)		multiple interactions	EXP	19	45,910,591	45,927,177	RGD:6480464	CTD
G	ERCC1	excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)		multiple interactions	EXP	19	45,910,591	45,927,177	RGD:6480464	CTD
G	ERCC1	excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)		multiple interactions	EXP	19	45,910,591	45,927,177	RGD:6480464	CTD
G	ERCC1	excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)		multiple interactions	EXP	19	45,910,591	45,927,177	RGD:6480464	CTD
G	ERCC1	excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)		multiple interactions	EXP	19	45,910,591	45,927,177	RGD:6480464	CTD
G	ERCC1	excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)		multiple interactions	EXP	19	45,910,591	45,927,177	RGD:6480464	CTD
G	ERCC1	excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)		multiple interactions	EXP	19	45,910,591	45,927,177	RGD:6480464	CTD
G	ERCC1	excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)		decreases response to substance	EXP	19	45,910,591	45,927,177	RGD:6480464	CTD
G	ERCC1	excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)		increases response to substance	EXP	19	45,910,591	45,927,177	RGD:6480464	CTD
G	ERCC1	excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)		decreases response to substance	EXP	19	45,910,591	45,927,177	RGD:6480464	CTD
G	ERCC1	excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)		decreases response to substance	ISO	19	45,910,591	45,927,177	RGD:6480464	CTD
G	ERCC2	excision repair cross-complementing rodent repair deficiency, complementation group 2		decreases response to substance	EXP	19	45,854,649	45,873,845	RGD:6480464	CTD
G	ERCC4	excision repair cross-complementing rodent repair deficiency, complementation group 4		increases expression	EXP	16	14,014,014	14,046,205	RGD:6480464	CTD
G	ERCC4	excision repair cross-complementing rodent repair deficiency, complementation group 4		multiple interactions	EXP	16	14,014,014	14,046,205	RGD:6480464	CTD
G	ERCC4	excision repair cross-complementing rodent repair deficiency, complementation group 4		multiple interactions	EXP	16	14,014,014	14,046,205	RGD:6480464	CTD
G	ERCC4	excision repair cross-complementing rodent repair deficiency, complementation group 4		decreases response to substance	EXP	16	14,014,014	14,046,205	RGD:6480464	CTD
G	ERCC5	excision repair cross-complementing rodent repair deficiency, complementation group 5		decreases response to substance	EXP	13	103,498,191	103,528,351	RGD:6480464	CTD
G	ERCC5	excision repair cross-complementing rodent repair deficiency, complementation group 5		multiple interactions	EXP	13	103,498,191	103,528,351	RGD:6480464	CTD
G	ERCC6	excision repair cross-complementing rodent repair deficiency, complementation group 6		multiple interactions	EXP	10	50,664,491	50,747,147	RGD:6480464	CTD
G	ERCC6	excision repair cross-complementing rodent repair deficiency, complementation group 6		increases response to substance	EXP	10	50,664,491	50,747,147	RGD:6480464	CTD
G	ERCC6	excision repair cross-complementing rodent repair deficiency, complementation group 6		decreases response to substance	ISO	10	50,664,491	50,747,147	RGD:6480464	CTD
G	ERVFRD-1	endogenous retrovirus group FRD, member 1		affects response to substance	EXP	6	11,102,722	11,112,071	RGD:6480464	CTD
G	ESAM	endothelial cell adhesion molecule		increases phosphorylation	ISO	11	124,623,019	124,632,223	RGD:6480464	CTD
G	ESAM	endothelial cell adhesion molecule		decreases expression	ISO	11	124,623,019	124,632,223	RGD:6480464	CTD
G	ESM1	endothelial cell-specific molecule 1		multiple interactions	EXP	5	54,273,695	54,281,414	RGD:6480464	CTD
G	ESR1	estrogen receptor 1		increases response to substance	EXP	6	152,011,631	152,424,409	RGD:6480464	CTD
G	ESR1	estrogen receptor 1		multiple interactions	EXP	6	152,011,631	152,424,409	RGD:6480464	CTD
G	ESRRB	estrogen-related receptor beta		decreases phosphorylation	ISO	14	76,837,690	76,968,180	RGD:6480464	CTD
G	ETS2	v-ets erythroblastosis virus E26 oncogene homolog 2 (avian)		increases expression	EXP	21	40,177,231	40,196,879	RGD:6480464	CTD
G	ETV4	ets variant 4		increases expression	EXP	17	41,605,211	41,623,800	RGD:6480464	CTD
G	ETV4	ets variant 4		decreases expression	ISO	17	41,605,211	41,623,800	RGD:6480464	CTD
G	EWSR1	Ewing sarcoma breakpoint region 1		increases expression	ISO	22	29,663,998	29,696,515	RGD:6480464	CTD
G	EXO1	exonuclease 1		decreases expression	ISO	1	242,011,493	242,053,241	RGD:6480464	CTD
G	EXOC3	exocyst complex component 3		multiple interactions	EXP	5	443,334	467,411	RGD:6480464	CTD
G	EXOC4	exocyst complex component 4		decreases expression	ISO	7	132,937,823	133,750,514	RGD:6480464	CTD
G	EXOSC8	exosome component 8		multiple interactions	EXP	13	37,574,678	37,583,751	RGD:6480464	CTD
G	EXTL1	exostosin-like glycosyltransferase 1		decreases expression	ISO	1	26,348,271	26,362,955	RGD:6480464	CTD
G	EZR	ezrin		increases expression	ISO	6	159,186,773	159,240,456	RGD:6480464	CTD
G	F3	coagulation factor III (thromboplastin, tissue factor)		decreases expression	ISO	1	94,994,732	95,007,413	RGD:6480464	CTD
G	F8A3	coagulation factor VIII-associated 3		affects response to substance	EXP	X	154,687,146	154,688,261	RGD:6480464	CTD
G	FABP1	fatty acid binding protein 1, liver		increases expression	ISO	2	88,422,501	88,427,650	RGD:6480464	CTD
G	FABP4	fatty acid binding protein 4, adipocyte		decreases expression	ISO	8	82,390,732	82,395,473	RGD:6480464	CTD
G	FABP5	fatty acid binding protein 5 (psoriasis-associated)		decreases expression	ISO	8	82,192,718	82,197,012	RGD:6480464	CTD
G	FADS1	fatty acid desaturase 1		affects response to substance	EXP	11	61,567,097	61,584,529	RGD:6480464	CTD
G	FAM101B	family with sequence similarity 101, member B		decreases expression	ISO	17	289,769	295,731	RGD:6480464	CTD
G	FAM129A	family with sequence similarity 129, member A		affects response to substance	EXP	1	184,760,166	184,943,682	RGD:6480464	CTD
G	FAS	Fas (TNF receptor superfamily, member 6)		increases expression	ISO	10	90,750,288	90,775,542	RGD:6480464	CTD
G	FASLG	Fas ligand (TNF superfamily, member 6)		multiple interactions	ISO	1	172,628,185	172,636,013	RGD:6480464	CTD
G	FASLG	Fas ligand (TNF superfamily, member 6)		multiple interactions	EXP	1	172,628,185	172,636,013	RGD:6480464	CTD
G	FASLG	Fas ligand (TNF superfamily, member 6)		increases expression	EXP	1	172,628,185	172,636,013	RGD:6480464	CTD
G	FASLG	Fas ligand (TNF superfamily, member 6)		increases expression	EXP	1	172,628,185	172,636,013	RGD:6480464	CTD
G	FASLG	Fas ligand (TNF superfamily, member 6)		multiple interactions	EXP	1	172,628,185	172,636,013	RGD:6480464	CTD
G	FASLG	Fas ligand (TNF superfamily, member 6)		multiple interactions	EXP	1	172,628,185	172,636,013	RGD:6480464	CTD
G	FASLG	Fas ligand (TNF superfamily, member 6)		increases expression	ISO	1	172,628,185	172,636,013	RGD:6480464	CTD
G	FASLG	Fas ligand (TNF superfamily, member 6)		multiple interactions	ISO	1	172,628,185	172,636,013	RGD:6480464	CTD
G	FASN	fatty acid synthase		multiple interactions	EXP	17	80,036,214	80,056,106	RGD:6480464	CTD
G	FASN	fatty acid synthase		increases expression	ISO	17	80,036,214	80,056,106	RGD:6480464	CTD
G	FASTK	Fas-activated serine/threonine kinase		increases expression	EXP	7	150,773,708	150,777,970	RGD:6480464	CTD
G	FBL	fibrillarin		decreases expression	ISO	19	40,325,093	40,337,054	RGD:6480464	CTD
G	FBLIM1	filamin binding LIM protein 1		decreases expression	ISO	1	16,085,255	16,113,084	RGD:6480464	CTD
G	FBN1	fibrillin 1		increases expression	ISO	15	48,700,503	48,937,985	RGD:6480464	CTD
G	FBP1	fructose-1,6-bisphosphatase 1		increases expression	ISO	9	97,365,415	97,402,531	RGD:6480464	CTD
G	FBXO32	F-box protein 32		increases expression	ISO	8	124,510,127	124,553,493	RGD:6480464	CTD
G	FBXO9	F-box protein 9		multiple interactions	EXP	6	52,929,796	52,965,671	RGD:6480464	CTD
G	FCER1G	Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide		decreases expression	ISO	1	161,185,087	161,189,038	RGD:6480464	CTD
G	FCGR3A	Fc fragment of IgG, low affinity IIIa, receptor (CD16a)		decreases expression	ISO	1	161,511,549	161,520,413	RGD:6480464	CTD
G	FCHSD2	FCH and double SH3 domains 2		decreases expression	EXP	11	72,547,790	72,853,143	RGD:6480464	CTD
G	FDFT1	farnesyl-diphosphate farnesyltransferase 1		multiple interactions	EXP	8	11,660,190	11,696,818	RGD:6480464	CTD
G	FDFT1	farnesyl-diphosphate farnesyltransferase 1		increases expression	ISO	8	11,660,190	11,696,818	RGD:6480464	CTD
G	FDXR	ferredoxin reductase		increases expression	EXP	17	72,858,619	72,869,156	RGD:6480464	CTD
G	FDXR	ferredoxin reductase		multiple interactions	EXP	17	72,858,619	72,869,156	RGD:6480464	CTD
G	FEN1	flap structure-specific endonuclease 1		affects response to substance	EXP	11	61,560,109	61,564,716	RGD:6480464	CTD
G	FEN1	flap structure-specific endonuclease 1		multiple interactions	EXP	11	61,560,109	61,564,716	RGD:6480464	CTD
G	FEN1	flap structure-specific endonuclease 1		decreases expression	ISO	11	61,560,109	61,564,716	RGD:6480464	CTD
G	FGD4	FYVE, RhoGEF and PH domain containing 4		decreases expression	EXP	12	32,655,041	32,798,984	RGD:6480464	CTD
G	FGF1	fibroblast growth factor 1 (acidic)		decreases expression	ISO	5	141,971,743	142,077,635	RGD:6480464	CTD
G	FGF13	fibroblast growth factor 13		decreases expression	ISO	X	137,713,734	138,287,185	RGD:6480464	CTD
G	FGF2	fibroblast growth factor 2 (basic)		multiple interactions	EXP	4	123,747,863	123,819,390	RGD:6480464	CTD
G	FGF21	fibroblast growth factor 21		decreases expression	ISO	19	49,259,344	49,261,582	RGD:6480464	CTD
G	FGF7	fibroblast growth factor 7		increases expression	ISO	15	49,715,375	49,779,523	RGD:6480464	CTD
G	FGF9	fibroblast growth factor 9 (glia-activating factor)		affects response to substance	EXP	13	22,245,215	22,278,640	RGD:6480464	CTD
G	FGFR1	fibroblast growth factor receptor 1		increases expression	ISO	8	38,268,656	38,326,352	RGD:6480464	CTD
G	FGFR2	fibroblast growth factor receptor 2		decreases expression	EXP	10	123,237,844	123,357,972	RGD:6480464	CTD
G	FGFR2	fibroblast growth factor receptor 2		affects response to substance	EXP	10	123,237,844	123,357,972	RGD:6480464	CTD
G	FGFR3	fibroblast growth factor receptor 3		increases expression	EXP	4	1,795,039	1,810,599	RGD:6480464	CTD
G	FGGY	FGGY carbohydrate kinase domain containing		decreases expression	ISO	1	59,762,625	60,228,402	RGD:6480464	CTD
G	FHIT	fragile histidine triad		decreases expression	ISO	3	59,735,036	61,237,133	RGD:6480464	CTD
G	FHL2	four and a half LIM domains 2		decreases expression	ISO	2	105,977,283	106,055,230	RGD:6480464	CTD
G	FHL2	four and a half LIM domains 2		increases expression	ISO	2	105,977,283	106,055,230	RGD:6480464	CTD
G	FKBP1B	FK506 binding protein 1B, 12.6 kDa		increases expression	ISO	2	24,272,584	24,286,551	RGD:6480464	CTD
G	FKBP2	FK506 binding protein 2, 13kDa		affects response to substance	EXP	11	64,008,413	64,011,607	RGD:6480464	CTD
G	FLII	flightless I homolog (Drosophila)		multiple interactions	EXP	17	18,148,129	18,162,230	RGD:6480464	CTD
G	FLNC	filamin C, gamma		decreases expression	ISO	7	128,470,483	128,499,328	RGD:6480464	CTD
G	FLT1	fms-related tyrosine kinase 1		increases expression	ISO	13	28,874,483	29,069,265	RGD:6480464	CTD
G	FLT3LG	fms-related tyrosine kinase 3 ligand		increases expression	ISO	19	49,977,466	49,989,488	RGD:6480464	CTD
G	FMOD	fibromodulin		affects response to substance	EXP	1	203,309,752	203,320,289	RGD:6480464	CTD
G	FN1	fibronectin 1		increases activity	EXP	2	216,225,177	216,300,791	RGD:6480464	CTD
G	FN1	fibronectin 1		increases expression	ISO	2	216,225,177	216,300,791	RGD:6480464	CTD
G	FOLR2	folate receptor 2 (fetal)		decreases response to substance	EXP	11	71,927,819	71,932,994	RGD:6480464	CTD
G	FOS	FBJ murine osteosarcoma viral oncogene homolog		affects response to substance	EXP	14	75,745,481	75,748,937	RGD:6480464	CTD
G	FOS	FBJ murine osteosarcoma viral oncogene homolog		increases expression	ISO	14	75,745,481	75,748,937	RGD:6480464	CTD
G	FOS	FBJ murine osteosarcoma viral oncogene homolog		decreases expression	ISO	14	75,745,481	75,748,937	RGD:6480464	CTD
G	FOS	FBJ murine osteosarcoma viral oncogene homolog		increases expression	ISO	14	75,745,481	75,748,937	RGD:6480464	CTD
G	FOS	FBJ murine osteosarcoma viral oncogene homolog		increases expression	ISO	14	75,745,481	75,748,937	RGD:6480464	CTD
G	FOS	FBJ murine osteosarcoma viral oncogene homolog		multiple interactions	ISO	14	75,745,481	75,748,937	RGD:6480464	CTD
G	FOSL1	FOS-like antigen 1		increases expression	EXP	11	65,659,692	65,667,997	RGD:6480464	CTD
G	FOSL1	FOS-like antigen 1		affects response to substance	EXP	11	65,659,692	65,667,997	RGD:6480464	CTD
G	FOSL1	FOS-like antigen 1		affects response to substance	EXP	11	65,659,692	65,667,997	RGD:6480464	CTD
G	FOSL1	FOS-like antigen 1		increases expression	ISO	11	65,659,692	65,667,997	RGD:6480464	CTD
G	FOXC1	forkhead box C1		affects response to substance	EXP	6	1,610,681	1,614,132	RGD:6480464	CTD
G	FOXM1	forkhead box M1		multiple interactions	EXP	12	2,966,847	2,986,321	RGD:6480464	CTD
G	FOXM1	forkhead box M1		increases expression	ISO	12	2,966,847	2,986,321	RGD:6480464	CTD
G	FRAS1	Fraser syndrome 1		multiple interactions	EXP	4	78,978,724	79,465,423	RGD:6480464	CTD
G	FST	follistatin		multiple interactions	EXP	5	52,776,264	52,782,304	RGD:6480464	CTD
G	FST	follistatin		decreases expression	ISO	5	52,776,264	52,782,304	RGD:6480464	CTD
G	FSTL1	follistatin-like 1		increases expression	ISO	3	120,113,061	120,169,918	RGD:6480464	CTD
G	FSTL1	follistatin-like 1		multiple interactions	ISO	3	120,113,061	120,169,918	RGD:6480464	CTD
G	FTLP3	ferritin, light polypeptide pseudogene 3		affects response to substance	EXP	20	4,004,365	4,005,253	RGD:6480464	CTD
G	FUBP1	far upstream element (FUSE) binding protein 1		decreases expression	ISO	1	78,413,591	78,444,777	RGD:6480464	CTD
G	FUT8	fucosyltransferase 8 (alpha (1,6) fucosyltransferase)		multiple interactions	EXP	14	65,877,310	66,210,839	RGD:6480464	CTD
G	FXR1	fragile X mental retardation, autosomal homolog 1		increases expression	ISO	3	180,630,234	180,700,541	RGD:6480464	CTD
G	FXYD5	FXYD domain containing ion transport regulator 5		decreases expression	ISO	19	35,645,625	35,660,788	RGD:6480464	CTD
G	G2E3	G2/M-phase specific E3 ubiquitin protein ligase		increases expression	ISO	14	31,028,329	31,089,046	RGD:6480464	CTD
G	G6PC	glucose-6-phosphatase, catalytic subunit		decreases expression	ISO	17	41,052,814	41,066,450	RGD:6480464	CTD
G	G6PD	glucose-6-phosphate dehydrogenase		increases expression	ISO	X	153,759,606	153,775,787	RGD:6480464	CTD
G	GABARAPL1	GABA(A) receptor-associated protein like 1		increases expression	ISO	12	10,365,489	10,375,727	RGD:6480464	CTD
G	GADD45A	growth arrest and DNA-damage-inducible, alpha		increases expression	EXP	1	68,150,860	68,154,021	RGD:6480464	CTD
G	GADD45A	growth arrest and DNA-damage-inducible, alpha		decreases expression	ISO	1	68,150,860	68,154,021	RGD:6480464	CTD
G	GADD45A	growth arrest and DNA-damage-inducible, alpha		increases expression	EXP	1	68,150,860	68,154,021	RGD:6480464	CTD
G	GADD45A	growth arrest and DNA-damage-inducible, alpha		increases response to substance	EXP	1	68,150,860	68,154,021	RGD:6480464	CTD
G	GADD45A	growth arrest and DNA-damage-inducible, alpha		multiple interactions	EXP	1	68,150,860	68,154,021	RGD:6480464	CTD
G	GADD45A	growth arrest and DNA-damage-inducible, alpha		increases expression	ISO	1	68,150,860	68,154,021	RGD:6480464	CTD
G	GADD45G	growth arrest and DNA-damage-inducible, gamma		decreases expression	ISO	9	92,219,927	92,221,470	RGD:6480464	CTD
G	GALNT7	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7)		affects response to substance	EXP	4	174,089,904	174,245,118	RGD:6480464	CTD
G	GAPDH	glyceraldehyde-3-phosphate dehydrogenase		increases expression	EXP	12	6,643,585	6,647,537	RGD:6480464	CTD
G	GAPVD1	GTPase activating protein and VPS9 domains 1		decreases phosphorylation	ISO	9	128,024,111	128,127,290	RGD:6480464	CTD
G	GARS	glycyl-tRNA synthetase		affects response to substance	EXP	7	30,634,181	30,673,649	RGD:6480464	CTD
G	GAS1	growth arrest-specific 1		decreases expression	ISO	9	89,559,277	89,562,104	RGD:6480464	CTD
G	GP1BB	glycoprotein Ib (platelet), beta polypeptide		decreases expression	ISO	22	19,711,066	19,712,297	RGD:6480464	CTD
G	GPAA1	glycosylphosphatidylinositol anchor attachment 1		affects response to substance	EXP	8	145,137,524	145,141,119	RGD:6480464	CTD
G	GPAA1	glycosylphosphatidylinositol anchor attachment 1		multiple interactions	EXP	8	145,137,524	145,141,119	RGD:6480464	CTD
G	GPC1	glypican 1		multiple interactions	EXP	2	241,375,115	241,407,495	RGD:6480464	CTD
G	GPR125	G protein-coupled receptor 125		decreases expression	ISO	4	22,388,997	22,517,677	RGD:6480464	CTD
G	GPR126	G protein-coupled receptor 126		decreases expression	ISO	6	142,623,056	142,767,403	RGD:6480464	CTD
G	GPR176	G protein-coupled receptor 176		decreases expression	ISO	15	40,092,931	40,213,093	RGD:6480464	CTD
G	GPR39	G protein-coupled receptor 39		decreases expression	EXP	2	133,174,147	133,404,169	RGD:6480464	CTD
G	GPR64	G protein-coupled receptor 64		decreases expression	ISO	X	19,007,425	19,140,755	RGD:6480464	CTD
G	GPX1	glutathione peroxidase 1		multiple interactions	ISO	3	49,394,609	49,395,791	RGD:6480464	CTD
G	GPX1	glutathione peroxidase 1		decreases expression	ISO	3	49,394,609	49,395,791	RGD:6480464	CTD
G	GPX3	glutathione peroxidase 3 (plasma)		affects response to substance	EXP	5	150,399,999	150,408,554	RGD:6480464	CTD
G	GPX3	glutathione peroxidase 3 (plasma)		decreases response to substance	EXP	5	150,399,999	150,408,554	RGD:6480464	CTD
G	GRAMD4	GRAM domain containing 4		multiple interactions	EXP	22	47,022,658	47,075,688	RGD:6480464	CTD
G	GRB10	growth factor receptor-bound protein 10		decreases expression	ISO	7	50,657,760	50,861,159	RGD:6480464	CTD
G	GRN	granulin		multiple interactions	EXP	17	42,422,491	42,430,470	RGD:6480464	CTD
G	GRN	granulin		increases expression	ISO	17	42,422,491	42,430,470	RGD:6480464	CTD
G	GRPEL1	GrpE-like 1, mitochondrial (E. coli)		increases expression	ISO	4	7,061,780	7,069,800	RGD:6480464	CTD
G	GSK3A	glycogen synthase kinase 3 alpha		decreases phosphorylation	EXP	19	42,734,338	42,746,736	RGD:6480464	CTD
G	GSK3B	glycogen synthase kinase 3 beta		multiple interactions	EXP	3	119,540,800	119,813,264	RGD:6480464	CTD
G	GSK3B	glycogen synthase kinase 3 beta		decreases expression	ISO	3	119,540,800	119,813,264	RGD:6480464	CTD
G	GSK3B	glycogen synthase kinase 3 beta		decreases phosphorylation	EXP	3	119,540,800	119,813,264	RGD:6480464	CTD
G	GSN	gelsolin		increases expression	ISO	9	124,030,380	124,095,120	RGD:6480464	CTD
G	GSR	glutathione reductase		multiple interactions	ISO	8	30,535,578	30,585,486	RGD:6480464	CTD
G	GSR	glutathione reductase		decreases activity	ISO	8	30,535,578	30,585,486	RGD:6480464	CTD
G	MT-CO2	mitochondrially encoded cytochrome c oxidase II		increases expression	ISO	MT	7,586	8,269	RGD:6480464	CTD
G	MYRF	myelin regulatory factor		affects response to substance	EXP	11	61,520,121	61,555,989	RGD:6480464	CTD
G	PLK3	polo-like kinase 3		increases expression	EXP	1	45,266,036	45,271,667	RGD:6480464	CTD
G	YBX3	Y box binding protein 3		multiple interactions	EXP	12	10,851,676	10,875,953	RGD:6480464	CTD

Term paths to the root

Path 1
Term	Annotations
CHEBI ontology	513708
role	503229
biological role	501402
aetiopathogenetic role	114227
mutagen	19165
cisplatin	4509
Path 2
Term	Annotations
CHEBI ontology	513708
subatomic particle	512601
composite particle	512601
hadron	512601
baryon	512601
nucleon	512601
atomic nucleus	512601
atom	512601
&nb